<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">52549</article-id><article-id pub-id-type="doi">10.7554/eLife.52549</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Short Report</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group></article-categories><title-group><article-title>c-Maf restrains T-bet-driven programming of CCR6-negative group 3 innate lymphoid cells</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-160490"><name><surname>Tizian</surname><given-names>Caroline</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/><xref ref-type="other" rid="dataset1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-160491"><name><surname>Lahmann</surname><given-names>Annette</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/><xref ref-type="other" rid="dataset1"/></contrib><contrib contrib-type="author" id="author-160492"><name><surname>Hölsken</surname><given-names>Oliver</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6086-9275</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/><xref ref-type="other" rid="dataset1"/></contrib><contrib contrib-type="author" id="author-173308"><name><surname>Cosovanu</surname><given-names>Catalina</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/><xref ref-type="other" rid="dataset1"/></contrib><contrib contrib-type="author" id="author-160493"><name><surname>Kofoed-Branzk</surname><given-names>Michael</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/><xref ref-type="other" rid="dataset1"/></contrib><contrib contrib-type="author" id="author-160494"><name><surname>Heinrich</surname><given-names>Frederik</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/><xref ref-type="other" rid="dataset1"/></contrib><contrib contrib-type="author" id="author-95063"><name><surname>Mashreghi</surname><given-names>Mir-Farzin</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-8015-6907</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/><xref ref-type="other" rid="dataset1"/></contrib><contrib contrib-type="author" id="author-160495"><name><surname>Kruglov</surname><given-names>Andrey</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/><xref ref-type="other" rid="dataset1"/></contrib><contrib contrib-type="author" id="author-160496"><name><surname>Diefenbach</surname><given-names>Andreas</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/><xref ref-type="other" rid="dataset1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-159993"><name><surname>Neumann</surname><given-names>Christian</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2202-1876</contrib-id><email>c.neumann@charite.de</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Laboratory of Innate Immunity, Department of Microbiology, Infectious Diseases and Immunology, Charité-Universitätsmedizin Berlin</institution><addr-line><named-content content-type="city">Berlin</named-content></addr-line><country>Germany</country></aff><aff id="aff2"><label>2</label><institution>Mucosal and Developmental Immunology, Deutsches Rheuma-Forschungszentrum</institution><addr-line><named-content content-type="city">Berlin</named-content></addr-line><country>Germany</country></aff><aff id="aff3"><label>3</label><institution>Chronic Immune Reactions, Deutsches Rheuma-Forschungszentrum</institution><addr-line><named-content content-type="city">Berlin</named-content></addr-line><country>Germany</country></aff><aff id="aff4"><label>4</label><institution>Therapeutic Gene Regulation, Deutsches Rheuma-Forschungszentrum</institution><addr-line><named-content content-type="city">Berlin</named-content></addr-line><country>Germany</country></aff><aff id="aff5"><label>5</label><institution>Chronic Inflammation, Deutsches Rheuma-Forschungszentrum</institution><addr-line><named-content content-type="city">Berlin</named-content></addr-line><country>Germany</country></aff><aff id="aff6"><label>6</label><institution>Belozersky Institute of Physico-Chemical Biology and Biological Faculty, M.V. Lomonosov Moscow State University</institution><addr-line><named-content content-type="city">Moscow</named-content></addr-line><country>Russian Federation</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="senior_editor"><name><surname>Rath</surname><given-names>Satyajit</given-names></name><role>Senior Editor</role><aff><institution>Indian Institute of Science Education and Research (IISER)</institution><country>India</country></aff></contrib><contrib contrib-type="editor"><name><surname>Rath</surname><given-names>Satyajit</given-names></name><role>Reviewing Editor</role><aff><institution>Indian Institute of Science Education and Research (IISER)</institution><country>India</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>10</day><month>02</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>9</volume><elocation-id>e52549</elocation-id><history><date date-type="received" iso-8601-date="2019-10-08"><day>08</day><month>10</month><year>2019</year></date><date date-type="accepted" iso-8601-date="2020-02-10"><day>10</day><month>02</month><year>2020</year></date></history><permissions><copyright-statement>© 2020, Tizian et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Tizian et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-52549-v3.pdf"/><abstract><p>RORγt<sup>+</sup> group 3 innate lymphoid cells (ILC3s) maintain intestinal homeostasis through secretion of type 3 cytokines such as interleukin (IL)−17 and IL-22. However, CCR6<sup>-</sup> ILC3s additionally co-express T-bet allowing for the acquisition of type 1 effector functions. While T-bet controls the type 1 programming of ILC3s, the molecular mechanisms governing T-bet are undefined. Here, we identify c-Maf as a crucial negative regulator of murine T-bet<sup>+</sup> CCR6<sup>-</sup> ILC3s. Phenotypic and transcriptomic profiling of c-Maf-deficient CCR6<sup>-</sup> ILC3s revealed a hyper type 1 differentiation status, characterized by overexpression of ILC1/NK cell-related genes and downregulation of type 3 signature genes. On the molecular level, c-Maf directly restrained T-bet expression. Conversely, c-Maf expression was dependent on T-bet and regulated by IL-1β, IL-18 and Notch signals. Thus, we define c-Maf as a crucial cell-intrinsic brake in the type 1 effector acquisition which forms a negative feedback loop with T-bet to preserve the identity of CCR6<sup>-</sup> ILC3s.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>innate lymphoid cells</kwd><kwd>transcriptional regulation</kwd><kwd>ILC3 plasticity</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>Priority Program 1937 &quot;Innate Lymphoid Cells&quot;</award-id><principal-award-recipient><name><surname>Diefenbach</surname><given-names>Andreas</given-names></name><name><surname>Neumann</surname><given-names>Christian</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100008530</institution-id><institution>European Regional Development Fund</institution></institution-wrap></funding-source><award-id>ERDF 2014-2020</award-id><principal-award-recipient><name><surname>Heinrich</surname><given-names>Frederik</given-names></name><name><surname>Mashreghi</surname><given-names>Mir-Farzin</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100008530</institution-id><institution>European Regional Development Fund</institution></institution-wrap></funding-source><award-id>EFRE 1.8/11</award-id><principal-award-recipient><name><surname>Mashreghi</surname><given-names>Mir-Farzin</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100006769</institution-id><institution>Russian Science Foundation</institution></institution-wrap></funding-source><award-id>17-74-20059</award-id><principal-award-recipient><name><surname>Kruglov</surname><given-names>Andrey</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>c-Maf is a novel key regulator of the type 3-to-1 conversion of CCR6<sup>–</sup> ILC3s that controls the functional plasticity of ILC3s by acting as a cell-intrinsic gatekeeper of T-bet expression.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Tissue-resident, RORγt-dependent group 3 innate lymphoid cells (ILC3s) protect mucosal surfaces against infections and maintain the integrity of the epithelial barrier by secretion of cytokines such as IL-17 and IL-22 (<xref ref-type="bibr" rid="bib53">Sonnenberg et al., 2012</xref>; <xref ref-type="bibr" rid="bib18">Gronke et al., 2019</xref>; <xref ref-type="bibr" rid="bib20">Hernández et al., 2015</xref>; <xref ref-type="bibr" rid="bib66">Zheng et al., 2008</xref>; <xref ref-type="bibr" rid="bib16">Gladiator et al., 2013</xref>; <xref ref-type="bibr" rid="bib46">Satoh-Takayama et al., 2008</xref>; <xref ref-type="bibr" rid="bib65">Zenewicz et al., 2008</xref>). In mice, ILC3s consist of two major subsets, CCR6<sup>+</sup> ILC3s that include lymphoid tissue inducer (LTi) cells and CCR6<sup>-</sup> ILC3s that can differentiate to cells expressing type 1 effector molecules, such as IFN-γ and the natural cytotoxic receptor NKp46 (<xref ref-type="bibr" rid="bib48">Sawa et al., 2010</xref>; <xref ref-type="bibr" rid="bib27">Klose et al., 2013</xref>). Functionally, fetal LTi and adult LTi-like CCR6<sup>+</sup> ILC3s are essential for lymphoid organ development (<xref ref-type="bibr" rid="bib55">Sun et al., 2000</xref>; <xref ref-type="bibr" rid="bib13">Eberl et al., 2004</xref>), while NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s are implicated in type 1 inflammatory immune responses and thus may also have pathogenic functions during intestinal inflammation (<xref ref-type="bibr" rid="bib27">Klose et al., 2013</xref>; <xref ref-type="bibr" rid="bib39">Powell et al., 2012</xref>; <xref ref-type="bibr" rid="bib6">Buonocore et al., 2010</xref>; <xref ref-type="bibr" rid="bib4">Bernink et al., 2013</xref>; <xref ref-type="bibr" rid="bib60">Vonarbourg et al., 2010</xref>; <xref ref-type="bibr" rid="bib41">Rankin et al., 2016</xref>; <xref ref-type="bibr" rid="bib52">Song et al., 2015</xref>).</p><p>The transcription factor (TF) RORγt is strictly required for the development of all ILC3s, as mice deficient for RORγt lack all ILC3 subsets (<xref ref-type="bibr" rid="bib13">Eberl et al., 2004</xref>; <xref ref-type="bibr" rid="bib45">Sanos et al., 2009</xref>). RORγt also controls the functionality of ILC3s by regulating the production of effector cytokines, such as IL-17 and IL-22 (<xref ref-type="bibr" rid="bib24">Ivanov et al., 2006</xref>; <xref ref-type="bibr" rid="bib44">Rutz et al., 2013</xref>). Interestingly, CCR6<sup>-</sup> ILC3 co-express RORγt and the master regulator of type 1 immunity, T-bet. T-bet is key to the differentiation of NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s, as those cells fail to develop in mice lacking the gene encoding T-bet, <italic>Tbx21</italic> (<xref ref-type="bibr" rid="bib27">Klose et al., 2013</xref>; <xref ref-type="bibr" rid="bib40">Rankin et al., 2013</xref>). Importantly, T-bet not only contributes to NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3 development, but an increasing T-bet gradient enables functional plasticity of NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s by instructing a type 1 effector program in ILC3s (<xref ref-type="bibr" rid="bib27">Klose et al., 2013</xref>; <xref ref-type="bibr" rid="bib50">Sciumé et al., 2012</xref>; <xref ref-type="bibr" rid="bib28">Klose et al., 2014</xref>; <xref ref-type="bibr" rid="bib8">Cella et al., 2019</xref>). Tunable T-bet expression in NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s serves as a dynamic molecular switch from a type 3 to a type 1 phenotype (<xref ref-type="bibr" rid="bib27">Klose et al., 2013</xref>). Once T-bet expression reaches a sufficient level, it can also act as a repressor of RORγt, resulting eventually in a full conversion of ILC3s to ILC1-like cells (referred to as ILC3-to-1 plasticity) (<xref ref-type="bibr" rid="bib60">Vonarbourg et al., 2010</xref>; <xref ref-type="bibr" rid="bib8">Cella et al., 2019</xref>; <xref ref-type="bibr" rid="bib5">Bernink et al., 2015</xref>). Thus, the balance between RORγt versus T-bet expression dictates the fate and function of CCR6<sup>-</sup> ILC3s (<xref ref-type="bibr" rid="bib15">Fang and Zhu, 2017</xref>).</p><p>Importantly, the molecular mechanisms controlling the dynamic and quantitative co-expression of RORγt and T-bet in CCR6<sup>-</sup> ILC3s are largely undefined. Several extrinsic signals were shown to promote or restrain T-bet-dependent plasticity, most prominently cues from the microbiota, IL-23, IL-7 and Notch signaling (<xref ref-type="bibr" rid="bib27">Klose et al., 2013</xref>; <xref ref-type="bibr" rid="bib45">Sanos et al., 2009</xref>; <xref ref-type="bibr" rid="bib40">Rankin et al., 2013</xref>; <xref ref-type="bibr" rid="bib58">Viant et al., 2016</xref>; <xref ref-type="bibr" rid="bib9">Chea et al., 2016</xref>). Moreover, exposure to pro-inflammatory cytokines, such as IL-12, IL-15 and IL-18, was reported to further support transdifferentiation to an ILC1-like fate (<xref ref-type="bibr" rid="bib60">Vonarbourg et al., 2010</xref>; <xref ref-type="bibr" rid="bib5">Bernink et al., 2015</xref>; <xref ref-type="bibr" rid="bib47">Satoh-Takayama et al., 2010</xref>). However, despite this, the intrinsic molecular mediators governing ILC3 plasticity have not been discovered yet.</p><p>In the past, our group and others could identify the AP-1 TF c-Maf as a central regulator of RORγt<sup>+</sup> CD4<sup>+</sup> T cells, including RORγt<sup>+</sup> Foxp3<sup>+</sup> Treg cells (<xref ref-type="bibr" rid="bib36">Neumann et al., 2019</xref>; <xref ref-type="bibr" rid="bib63">Xu et al., 2018</xref>; <xref ref-type="bibr" rid="bib62">Wheaton et al., 2017</xref>), RORγt<sup>+</sup> Th17 cells (<xref ref-type="bibr" rid="bib10">Ciofani et al., 2012</xref>; <xref ref-type="bibr" rid="bib3">Aschenbrenner et al., 2018</xref>; <xref ref-type="bibr" rid="bib57">Tanaka et al., 2014</xref>) and RORγt<sup>+</sup> γδ T cells (<xref ref-type="bibr" rid="bib67">Zuberbuehler et al., 2019</xref>), both in mouse and human. Specifically, c-Maf was shown to directly bind and regulate key genes of RORγt<sup>+</sup> T cells, including IL-22 and RORγt itself (<xref ref-type="bibr" rid="bib57">Tanaka et al., 2014</xref>; <xref ref-type="bibr" rid="bib67">Zuberbuehler et al., 2019</xref>; <xref ref-type="bibr" rid="bib43">Rutz et al., 2011</xref>). Recently, a broad transcriptional network analysis also identified c-Maf as an important regulator of the ILC3-ILC1 balance, although the precise underlying molecular mechanisms have remained unclear (<xref ref-type="bibr" rid="bib38">Pokrovskii et al., 2019</xref>).</p><p>Here, we demonstrate that c-Maf was essential for CCR6<sup>-</sup> ILC3s to establish a physiological equilibrium between type 1 and type 3 effector states. c-Maf directly restrained T-bet expression, thereby preventing CCR6<sup>-</sup> ILC3s from acquiring excessive type 1 effector functions. c-Maf expression itself was dependent on T-bet and tightly correlated with its expression level. Upstream, we identified IL-1ß- and IL-18-mediated NF-κB, as well as Notch signals, as potent extrinsic enhancers of c-Maf expression in CCR6<sup>-</sup> ILC3s. Thus, our data define c-Maf as an integral regulator within the type 3-to-1 conversion program that acts as a cell-intrinsic gatekeeper of T-bet expression to maintain the function and lineage-stability of CCR6<sup>-</sup> ILC3s.</p></sec><sec id="s2" sec-type="results|discussion"><title>Results and discussion</title><sec id="s2-1"><title>c-Maf specifically preserves the type 3 identity of CCR6<sup>-</sup> ILC3s</title><p>Given the pivotal role of c-Maf in CD4<sup>+</sup> T cells, we aimed to define its function in ILCs, which share a similar transcriptional program with T cells (<xref ref-type="bibr" rid="bib59">Vivier et al., 2018</xref>). We first investigated the expression pattern of c-Maf in different ILC subsets of the small intestinal lamina propria (siLP) by staining for c-Maf. This analysis showed that ILC3s expressed higher levels of c-Maf when compared to ILC1s or ILC2s (<xref ref-type="fig" rid="fig1">Figure 1A</xref>, gating strategy see <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). Among the ILC3 subsets, c-Maf was particularly highly expressed by NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s at levels comparable to RORγt<sup>+</sup> CD4<sup>+</sup> T cells (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). Collectively, these data suggested a potential function of c-Maf in these cells.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>c-Maf is required to maintain the type 3 phenotype of CCR6<sup>-</sup> ILC3s.</title><p>(<bold>A</bold>) Protein expression of c-Maf by ILC1s, ILC2s and ILC3s isolated from the siLP of naïve C57BL/6N wild-type mice as measured by flow cytometry (pregated on viable Lin<sup>-</sup> CD127<sup>+</sup> cells). Representative histograms show c-Maf expression. (<bold>B</bold>) Representative histograms showing expression of c-Maf by different siLP ILC3 subsets and RORγt<sup>+</sup> T cells as comparison. (<bold>C</bold>) Frequencies and total numbers of ILC1s, ILC2s and ILC3s from siLP of <italic>Rorc</italic><sup>Cre</sup> <italic>Maf</italic><sup>fl/fl</sup> and control mice as measured by flow cytometry (pregated on viable Lin<sup>-</sup> CD127<sup>+</sup> cells). Representative flow cytometric profiles of RORγt vs. T-bet and GATA3 expression (left); right, quantification (n = 5–6, mean ± SEM, *p&lt;0.05, **p&lt;0.01). (<bold>D</bold>) Total numbers of different siLP ILC3 subsets of <italic>Rorc</italic><sup>Cre</sup> <italic>Maf</italic><sup>fl/fl</sup> and control mice as measured by flow cytometry. Representative flow cytometric profiles of NKp46 vs. CCR6 expression (left); right, quantification (n = 5–6, mean ± SEM, *p&lt;0.05). (<bold>E</bold>) Expression of RORγt by different siLP ILC3 subsets from <italic>Rorc</italic><sup>Cre</sup> <italic>Maf</italic><sup>fl/fl</sup> and control mice. Representative histograms (upper panel) show RORγt expression. Graphs below show quantification of RORγt gMFI (n = 5–6, mean ± SEM, **p&lt;0.01, ***p&lt;0.001). (<bold>F, G</bold>) Frequencies of IL-17A and IL-22 positive cells among different siLP ILC3 subsets of <italic>Rorc</italic><sup>Cre</sup><italic>Maf</italic><sup>fl/fl</sup> and control mice after ex vivo restimulation with PMA/ionomycin and IL-23. Representative flow cytometric profiles of IL-17A or IL-22 vs. CCR6 are shown on the left; quantification on the right (<italic>n</italic> = 4, mean ± SEM, *p&lt;0.05, **p&lt;0.01). Data are representative of three independent experiments. Statistical differences were tested using an unpaired Students’ <italic>t</italic>-test (two-tailed).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-52549-fig1-v3.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Gating strategy to identify intestinal ILC1s, ILC2s, ILC3s and RORγt<sup>+</sup> T cells.</title><p>Representative flow cytometric staining of siLP cells with different lineage-defining surface markers and transcription factors. ILCs were defined as CD45<sup>+</sup> Lineage<sup>-</sup> (Lin<sup>-</sup>) CD3<sup>-</sup> CD127<sup>+</sup> cells. ILC1s were additionally defined as RORγt<sup>-</sup> T-bet<sup>+</sup>, ILC2s as RORγt<sup>-</sup> GATA3<sup>+</sup> and ILC3s as RORγt<sup>+</sup>. Lineage includes anti-B220, anti-Gr1, anti-FcεRIα, anti-F4/80, anti-CD11c, anti-CD11b and anti-CD5. RORγt<sup>+</sup> T cells were pregated on CD45<sup>+</sup> CD3<sup>+</sup> CD4<sup>+</sup> TCRß<sup>+</sup> cells.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-52549-fig1-figsupp1-v3.tif"/></fig></fig-group><p>In order to directly study the role of c-Maf in ILC3s, we crossed mice carrying floxed <italic>Maf</italic> alleles (<italic>Maf</italic><sup>fl/fl</sup>) to mice expressing Cre recombinase driven by the regulatory elements of the <italic>Rorc(γt)</italic> gene locus (<italic>Rorc-</italic>Cre<sup>Tg</sup>), thereby generating mice with a specific deletion of c-Maf in RORγt<sup>+</sup> ILC3s and T cells (<italic>Rorc</italic><sup>Cre</sup> <italic>Maf</italic><sup>fl/fl</sup>). Phenotypic analysis of siLP ILCs revealed decreased frequencies of ILC3s in the absence of c-Maf, whereas frequencies and total numbers of ILC1s and ILC2s were increased in <italic>Rorc</italic><sup>Cre</sup> <italic>Maf</italic><sup>fl/fl</sup> mice when compared to littermate controls (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). Among ILC3s, we detected a selective loss of NKp46<sup>-</sup> CCR6<sup>-</sup> ILC3s in <italic>Rorc</italic><sup>Cre</sup> <italic>Maf</italic><sup>fl/fl</sup> mice, while total numbers of NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s and CCR6<sup>+</sup> ILC3s were not significantly changed (<xref ref-type="fig" rid="fig1">Figure 1D</xref>).</p><p>Thus, c-Maf was selectively required for the maintenance of intestinal NKp46<sup>-</sup> CCR6<sup>-</sup> ILC3s. Its absence in ILC3s resulted in significant changes in the proportions of individual ILC subsets in the gut. Importantly, flow cytometric intracellular staining also revealed a significant downregulation of RORγt protein levels in c-Maf-deficient NKp46<sup>+</sup> and NKp46<sup>-</sup> CCR6<sup>-</sup> ILC3s, which was not observed in CCR6<sup>+</sup> ILC3s (<xref ref-type="fig" rid="fig1">Figure 1E</xref>).</p><p>Next, we tested the functionality of c-Maf-deficient ILC3s by assessing their capacity to produce the type 3 signature cytokines IL-17A and IL-22. In line with the decrease in RORγt expression, NKp46<sup>+</sup> and NKp46<sup>-</sup> CCR6<sup>-</sup> ILC3s from <italic>Rorc</italic><sup>Cre</sup> <italic>Maf</italic><sup>fl/fl</sup> mice exhibited significantly reduced frequencies of IL-17A and IL-22 producers after ex vivo restimulation as compared to control cells (<xref ref-type="fig" rid="fig1">Figure 1F and G</xref>). Again, no differences were detected in CCR6<sup>+</sup> ILC3s, corroborating the selective role of c-Maf for the homeostasis and function of CCR6<sup>-</sup> ILC3s. Notably, c-Maf did not act as a repressor of IL-22 production in ILC3s, as it was shown for Th17 cells (<xref ref-type="bibr" rid="bib43">Rutz et al., 2011</xref>), indicating essential differences in c-Maf function between ILCs and T cells.</p><p>In summary, these findings demonstrated a crucial requirement of c-Maf in maintaining the type 3 identity of CCR6<sup>-</sup> ILC3s, including their expression of RORγt, IL-17A and IL-22.</p></sec><sec id="s2-2"><title>c-Maf suppresses the acquisition of type 1 properties by CCR6<sup>-</sup> ILC3s</title><p>RORγt<sup>+</sup> CCR6<sup>-</sup> ILC3s have the capacity to acquire type 1 effector characteristics, such as IFN-γ and NKp46 expression (<xref ref-type="bibr" rid="bib60">Vonarbourg et al., 2010</xref>). This differentiation is facilitated by graded co-expression of T-bet, together with RORγt, enabling functional flexibility during inflammatory immune responses (<xref ref-type="bibr" rid="bib27">Klose et al., 2013</xref>; <xref ref-type="bibr" rid="bib39">Powell et al., 2012</xref>; <xref ref-type="bibr" rid="bib4">Bernink et al., 2013</xref>; <xref ref-type="bibr" rid="bib40">Rankin et al., 2013</xref>; <xref ref-type="bibr" rid="bib50">Sciumé et al., 2012</xref>). However, the molecular mechanisms governing the T-bet-dependent type 1 programming of CCR6<sup>-</sup> ILC3s are undefined.</p><p>Interestingly, c-Maf expression strongly correlated with T-bet expression in both NKp46<sup>+</sup> and NKp46<sup>-</sup> CCR6<sup>-</sup> ILC3s (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). More importantly, c-Maf deficiency resulted in strong upregulation of T-bet and NKp46 expression, both on the population (frequencies) and at single cell level (gMFI), in CCR6<sup>-</sup> ILC3s (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). These data, together with the selective loss of NKp46<sup>-</sup> CCR6<sup>-</sup> ILC3s, which are considered to contain precursors of NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s, in <italic>Rorc</italic><sup>Cre</sup><italic>Maf</italic><sup>fl/fl</sup> mice (<xref ref-type="fig" rid="fig1">Figure 1D</xref>), suggested an amplified type 1 conversion of CCR6<sup>-</sup> ILC3s in the absence of c-Maf.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>CCR6<sup>-</sup> ILC3s acquire a hyper type 1 phenotype in the absence of c-Maf.</title><p>(<bold>A</bold>) Representative flow cytometric profiles of T-bet vs. c-Maf expression by siLP NKp46<sup>+</sup> and NKp46<sup>-</sup> CCR6<sup>-</sup> ILC3s. (<bold>B</bold>) T-bet and NKp46 expression (frequency and gMFI) by siLP CCR6<sup>-</sup> ILC3s of <italic>Rorc</italic><sup>Cre</sup><italic>Maf</italic><sup>fl/fl</sup> and control mice. Representative flow cytometric profiles are shown on the left; quantification on the right (<italic>n</italic> = 4, mean ± SEM, **p&lt;0.01, ***p&lt;0.001). (<bold>C</bold>) Frequency of IFN-γ positive cells among siLP CCR6<sup>-</sup> ILC3s of <italic>Rorc</italic><sup>Cre</sup><italic>Maf</italic><sup>fl/fl</sup> and control mice after ex vivo restimulation with PMA/ionomycin and IL-23. Representative flow cytometric profiles are shown on the left; quantification on the right (<italic>n</italic> = 4, mean ± SEM, ***p&lt;0.001). (<bold>D</bold>) Analysis of mixed bone marrow chimeras of CD45.1<sup>+</sup> wild-type and CD45.2<sup>+</sup> <italic>Rorc</italic><sup>Cre</sup><italic>Maf</italic><sup>fl/f</sup> (Maf KO) bone marrow cells. Pregated on viable Lin<sup>-</sup> CD127<sup>+</sup> CD90.2<sup>+</sup> RORγt<sup>+</sup> cells. Recipient mice were CD90.1 positive. Representative flow cytometric profiles of T-bet vs. CCR6 expression are shown left; quantification on the right (<italic>n</italic> = 7, mean ± SEM, **p&lt;0.01). All statistical differences were tested using an unpaired Students’ <italic>t</italic>-test (two-tailed). (<bold>E</bold>) NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s were sorted from siLP of <italic>Rorc</italic><sup>Cre</sup><italic>Maf</italic><sup>fl/fl</sup> and control mice and subjected to RNA sequencing. Vulcano plot showing comparison of gene expression between c-Maf-deficient and control NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s. Data represent the combined analysis of three biologically independent samples. Genes considered significant (FC &gt; 1.5, FDR &lt; 0.05) fall into the grey background, while selected genes are highlighted in red. (<bold>F</bold>) Gene set enrichment plots showing enrichment of ILC1 and NK cell signature genes in c-Maf-deficient vs. control NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s (FDR &lt; 0.01). Normalized enrichment score (NES).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-52549-fig2-v3.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>c-Maf cell-intrinsically restrains the type 1 conversion of CCR6<sup>-</sup> ILC3s.</title><p>(<bold>A</bold>) Frequencies of Ki67<sup>+</sup> cells among siLP CCR6<sup>-</sup> ILC3s from <italic>Rorc</italic><sup>Cre</sup> <italic>Maf</italic><sup>fl/fl</sup> and control mice. Representative contour plots are shown left; graph on the right shows quantification (n = 4). (<bold>B</bold>) Frequency of T-bet<sup>+</sup> cells among siLP CCR6<sup>-</sup> ILC3s from <italic>CD4</italic><sup>Cre</sup> <italic>Maf</italic><sup>fl/fl</sup> and control mice (n = 4). (<bold>C</bold>) T-bet and NKp46 expression level (gMFI) of siLP c-Maf<sup>-</sup> (<bold>I</bold>) and c-Maf<sup>+</sup> (II) CD4<sup>+</sup> T-bet<sup>+</sup> CCR6<sup>-</sup> ILC3s from <italic>Cd4</italic><sup>Cre</sup> <italic>Maf</italic><sup>fl/fl</sup> and control mice. Representative flow cytometric profiles of CD4 vs. CCR6 and T-bet vs. c-Maf expression (left); right, quantification (n = 4, mean ± SEM, *p&lt;0.05, **p&lt;0.01). All statistical differences were tested using an unpaired Students’ <italic>t</italic>-test (two-tailed).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-52549-fig2-figsupp1-v3.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>RNA-Seq analysis of intestinal NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s and CCR6<sup>+</sup> ILC3s.</title><p>(<bold>A</bold>) Gating strategy for FACS-sorting of siLP ILC3s from <italic>Rorc</italic><sup>Cre</sup> <italic>Maf</italic><sup>fl/fl</sup> and <italic>Maf</italic><sup>fl/fl</sup> control mice for RNA-seq analysis. ILC3s were defined as viable CD45<sup>+</sup> Lin<sup>-</sup> CD127<sup>+</sup> KLRG1<sup>-</sup> NK1.1<sup>-</sup> cells. Lineage includes anti-CD5, anti-CD8α, anti-CD3, anti-Gr-1, anti-TCRγδ, anti-FcεRIα, anti-CD19 and anti-CD11c. (<bold>B</bold>) RNA-seq based principal component analysis (PCA) of FACS-sorted ILC3s. Each dot represents an individual biological replicate. (<bold>C</bold>) Venn diagram displaying the overlap between genes differentially expressed between c-Maf-deficient and control NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s and CCR6<sup>+</sup> ILC3s. (<bold>D, E</bold>) RNA-seq based expression of <italic>Bcl6</italic> (<bold>D</bold>) and <italic>Irf8</italic> (<bold>E</bold>) in c-Maf-deficient vs. control NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s and CCR6<sup>+</sup> ILC3s. Each dot represents an individual biological replicate.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-52549-fig2-figsupp2-v3.tif"/></fig></fig-group><p>In accordance with the increase in T-bet expression, we also detected increased frequencies of IFN-γ producing cells within c-Maf-deficient CCR6<sup>-</sup> ILC3s as compared to c-Maf-competent control cells (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). Of note, Ki67 staining of c-Maf-deficient CCR6<sup>-</sup> ILC3s was not altered, ruling out that proliferative differences facilitated the skewing towards a type 1 phenotype in the absence of c-Maf (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>).</p><p>In addition to the lack of c-Maf expression in ILC3s, <italic>Rorc</italic><sup>Cre</sup> <italic>Maf</italic><sup>fl/fl</sup> mice also harbour a c-Maf-deficient T cell compartment, due to the expression of RORγt during T cell development (<xref ref-type="bibr" rid="bib55">Sun et al., 2000</xref>). Moreover, conditional deletion of c-Maf in T cells (<italic>Cd4</italic><sup>Cre</sup> <italic>Maf</italic><sup>fl/fl</sup> or <italic>Foxp3</italic><sup>Cre</sup> <italic>Maf</italic><sup>fl/fl</sup>) was reported to cause disturbances in intestinal homeostasis (<xref ref-type="bibr" rid="bib36">Neumann et al., 2019</xref>; <xref ref-type="bibr" rid="bib23">Imbratta et al., 2019</xref>), raising the possibility that changes in the gut microenvironment contributed to the ‘hyper type 1’ phenotype of CCR6<sup>-</sup> ILC3s in <italic>Rorc</italic><sup>Cre</sup> <italic>Maf</italic><sup>fl/fl</sup> mice. To interrogate this scenario, we analysed intestinal CCR6<sup>-</sup> ILC3s from <italic>Cd4</italic><sup>Cre</sup> <italic>Maf</italic><sup>fl/fl</sup> mice. The expression of T-bet by CCR6<sup>-</sup> ILC3s was not altered when c-Maf was selectively deleted in T cells, excluding that T cell-dependent alterations affected the type 1 conversion of ILC3s in <italic>Rorc</italic><sup>Cre</sup> <italic>Maf</italic><sup>fl/fl</sup> mice (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>).</p><p>Interestingly, a small subset of CCR6<sup>-</sup> ILC3s also co-expresses CD4 (ca. 2% of CCR6<sup>-</sup> ILC3s, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C</xref>). Indeed, c-Maf staining of CD4<sup>+</sup> CCR6<sup>-</sup> ILC3s from <italic>Cd4</italic><sup>Cre</sup> <italic>Maf</italic><sup>fl/fl</sup> mice confirmed c-Maf deletion in a substantial fraction of cells (ca. 50%), allowing us to compare c-Maf-competent and c-Maf-deficient CCR6<sup>-</sup> ILC3s within the same mouse (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C</xref>). We detected higher expression of T-bet and NKp46 in cells lacking c-Maf as compared to their c-Maf-expressing counterparts, indicating that the type 1 deviation of c-Maf-deficient CCR6<sup>-</sup> ILC3s was a cell-intrinsic phenomenon (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C</xref>). Importantly, mixed bone marrow chimeras of wild-type and c-Maf-deficient cells confirmed the cell-intrinsic function of c-Maf in restraining T-bet expression (<xref ref-type="fig" rid="fig2">Figure 2D</xref>).</p><p>Together, these data identified c-Maf as a potent repressor of the T-bet-dependent type 1 conversion of CCR6<sup>-</sup> ILC3s. Notably, c-Maf has also been shown to attenuate the differentiation of Th1 cells by a yet-to-be-defined mechanism (<xref ref-type="bibr" rid="bib21">Ho et al., 1998</xref>), suggesting a broader role of c-Maf in restraining type 1 immune effector cells.</p></sec><sec id="s2-3"><title>c-Maf globally restrains type 1 and NK cell specific gene programs in CCR6<sup>-</sup> ILC3s</title><p>To better define c-Maf-dependent gene regulation, we performed RNA sequencing (RNA-seq) of siLP ILC3s of <italic>Rorc</italic><sup>Cre</sup><italic>Maf</italic><sup>fl/fl</sup> and control mice. We isolated NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s and as a comparison CCR6<sup>+</sup> ILC3s for our analysis (sorting strategy see <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2A</xref>). Principal component analysis showed that c-Maf-deficient ILC3s clustered separately from their wild-type counterparts, demonstrating a unique role of c-Maf in shaping the transcriptome of ILC3s (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2B</xref>).</p><p>We identified 941 genes as differentially expressed (FC &gt; 1.5, p-value &lt; 0.05) between c-Maf-deficient and control NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s (<xref ref-type="fig" rid="fig2">Figure 2E</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). Interestingly, only ca. 30% of these genes (294 genes) were also found to be differentially expressed in CCR6<sup>+</sup> ILC3s (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2C</xref>, <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>), indicating a distinct function of c-Maf in NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s. Consistent with our flow cytometry data, we detected a striking enrichment of type 1 and NK cell-related genes (e.g. <italic>Tbx21</italic>, <italic>Ifng</italic>, <italic>Nos2</italic>, <italic>Klri2</italic>, <italic>Klrc1</italic>, <italic>Klrc2</italic>, <italic>Gzmb</italic>, <italic>Gzmd</italic>, <italic>Fasl</italic>) in c-Maf-deficient NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s (<xref ref-type="fig" rid="fig2">Figure 2E</xref>). In line with this, <italic>Bcl6</italic> and <italic>Irf8</italic>, both recently described as crucial transcription factors promoting ILC1/NK cell gene programs (<xref ref-type="bibr" rid="bib38">Pokrovskii et al., 2019</xref>; <xref ref-type="bibr" rid="bib1">Adams et al., 2018</xref>), were also significantly upregulated in the absence of c-Maf in NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s (<xref ref-type="fig" rid="fig2">Figure 2E</xref>, <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2D and E</xref>). Conversely, several type 3 effector genes (e.g. <italic>Il17a</italic>, <italic>Il17f</italic>, <italic>Il17re</italic>, <italic>Ccl20</italic>) were downregulated in NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s upon c-Maf-deficiency (<xref ref-type="fig" rid="fig2">Figure 2E</xref>).</p><p>To better understand the global c-Maf-dependent changes in gene expression programs, we performed gene set enrichment analysis (GSEA). Given the strong upregulation of type 1 and NK cell features in c-Maf-deficient CCR6<sup>-</sup> ILC3s, we made use of published RNA-seq data comparing ILC1s and NK cells with CCR6<sup>-</sup> ILC3s (<xref ref-type="bibr" rid="bib38">Pokrovskii et al., 2019</xref>). In detail, we created sets of genes that were most highly overexpressed in ILC1s or NK cells, thereby defining ILC1 and NK cell gene signatures that distinctly separated those lineages from CCR6<sup>-</sup> ILC3s. Importantly, when applied to GSEA, both gene signatures were significantly enriched in c-Maf-deficient NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s (<xref ref-type="fig" rid="fig2">Figure 2F</xref>), indicating a global shift in gene expression towards an ILC1/NK cell phenotype.</p><p>In summary, these data demonstrated that c-Maf was essential to globally balance type 1 and type 3 gene programs within CCR6<sup>-</sup> ILC3s. This function of c-Maf was specific to NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s as opposed to CCR6<sup>+</sup> ILC3s, most likely due to the particularly high c-Maf expression and the selective accessible of type 1 gene loci in these cells (<xref ref-type="bibr" rid="bib38">Pokrovskii et al., 2019</xref>; <xref ref-type="bibr" rid="bib51">Shih et al., 2016</xref>). In the absence of c-Maf, NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s downregulated type 3 effector genes, while overexpressing numerous genes encoding for type 1 and cytotoxic effector molecules. The latter finding is particularly interesting, since NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s are largely considered to be non-toxic cells (<xref ref-type="bibr" rid="bib34">Melo-Gonzalez and Hepworth, 2017</xref>). Nevertheless, NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s share a considerable transcriptional overlap with ILC1s, which also exhibit a degree of cytotoxic capacity (<xref ref-type="bibr" rid="bib42">Robinette et al., 2015</xref>; <xref ref-type="bibr" rid="bib11">Cortez and Colonna, 2016</xref>). Thus, c-Maf-deficiency may result in marked cytotoxicity of NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s. More work is needed to precisely define the role of c-Maf for ILC3 functionality during homeostasis and in the context of intestinal inflammation.</p></sec><sec id="s2-4"><title>c-Maf restrains T-bet expression by directly repressing the Tbx21 promoter</title><p>The strong upregulation of T-bet expression in c-Maf-deficient CCR6<sup>-</sup> ILC3s raised the possibility that c-Maf acted as a direct repressor of T-bet, thereby restraining the type 1 differentiation program. Indeed, in silico analysis identified <italic>Maf</italic> response elements (MARE) within the <italic>Tbx21</italic> promoter, as well as in a conserved distant <italic>Tbx21</italic> enhancer (<xref ref-type="bibr" rid="bib25">Kataoka et al., 1994</xref>; <xref ref-type="bibr" rid="bib64">Yang et al., 2007</xref>), both regions accessible in NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s as evidenced by ATAC-sequencing (<xref ref-type="bibr" rid="bib51">Shih et al., 2016</xref>; <xref ref-type="fig" rid="fig3">Figure 3A and B</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>c-Maf directly represses T-bet as part of a negative feedback loop.</title><p>(<bold>A</bold>) Representative ATAC sequencing tracks across the <italic>Tbx21</italic> locus of NKp46<sup>+</sup> ILC3s (<xref ref-type="bibr" rid="bib51">Shih et al., 2016</xref>). The <italic>Tbx21</italic> promoter and enhancer regions are highlighted in red (<xref ref-type="bibr" rid="bib64">Yang et al., 2007</xref>). ATAC sequencing tracks were visualized using the WashU browser from the Cistrome project (<xref ref-type="bibr" rid="bib33">Mei et al., 2017</xref>). (<bold>B</bold>) Positioning of putative <italic>Maf</italic> response elements (MARE) within the <italic>Tbx21</italic> promoter and enhancer (highlighted in blue). Depicted sequences represent selected regions of the <italic>Tbx21</italic> promoter and enhancer. Mutated sequences are shown in lower lines in red. (<bold>C</bold>) Schematic representation of plasmids containing the <italic>Tbx21</italic> promoter/enhancer linked to the firefly luciferase reporter gene (Luc). Blue dots indicate MARE sites within the <italic>Tbx21</italic> promoter and enhancer region. (<bold>D</bold>) Relative luciferase activity (RLU) of different reporter constructs driven by the <italic>Tbx21</italic> promoter alone or in combination with an enhancer sequence compared to a promoterless (w/o) control vector (pGL3 basic) (n = 3, mean ± SEM, *p&lt;0.05, ***p&lt;0.001). (<bold>E</bold>) Analysis of c-Maf-dependent suppression of luciferase activity. The MARE sites within the <italic>Tbx21</italic> promoter or the <italic>Tbx21</italic> promoter and enhancer were mutated in the <italic>Tbx21</italic> enhancer/promoter construct. Comparison of RLU between unmutated and mutated <italic>Tbx21</italic> enhancer/promoter constructs upon c-Maf overexpression (n = 3, mean ± SEM, ***p&lt;0.001). All reporter assay data are pooled from three independent experiments. (<bold>F</bold>) Expression of c-Maf by siLP CCR6<sup>-</sup> ILC3s from T-bet-deficient (T-bet<sup>-/-</sup>) and -sufficient (T-bet<sup>+/+</sup>) mice. Representative flow cytometric profiles are shown on the left; graph on the right shows quantification of c-Maf gMFI (n = 4, mean ± SEM, ***p&lt;0.001). (<bold>G–H</bold>) Sort-purified siLP NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s from <italic>Rorc</italic><sup>Cre</sup> <italic>R26</italic><sup>EYFP</sup> mice were cultured in vitro for 36 hr in the presence of IL-7/SCF (w/o) or IL-7/SCF plus indicated cytokines. Subsequently, <italic>Maf</italic> expression was measured by qPCR (n = 4, mean ± SEM, *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001). In one condition the NF-κb inhibitor BMS-345541 (BMS) was added at 1 μM to the culture. Data are pooled from two independent experiments each with two replicate wells. (<bold>I</bold>) Sort-purified siLP NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s from <italic>Rorc</italic><sup>Cre</sup> <italic>R26</italic><sup>EYFP</sup> mice were cultured in the presence of IL-7/SCF on OP9 or OP9-DLL1 stromal cells as indicated. After 12 days, cells were analysed by flow cytometry for the cell surface expression of NKp46. Representative contour plots are shown on the left (pregated on CCR6<sup>-</sup> ILC3s); graph on the right shows quantification of the frequency of NKp46<sup>+</sup> cell among CCR6<sup>-</sup> ILC3s (n = 10, mean ± SEM, ***p&lt;0.001). Data are pooled from two independent experiments with 4 to 6 replicate wells. (<bold>J</bold>) Expression of c-Maf by NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s cultured on OP9 or OP9-DLL1 cells. Representative histogram is shown left; graph on the right shows quantification of c-Maf gMFI (n = 10, mean ± SEM, ***p&lt;0.001). All statistical differences were tested using an unpaired Students’ <italic>t</italic>-test (two-tailed).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-52549-fig3-v3.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Evidence for direct binding of T-bet to <italic>Maf</italic> in NKp46<sup>+</sup> ILC3s.</title><p>(<bold>A</bold>) Representative ATAC sequencing tracks across the <italic>Maf</italic> locus of NKp46<sup>+</sup> ILC3s (<xref ref-type="bibr" rid="bib51">Shih et al., 2016</xref>). ATAC sequencing peaks overlap with two conserved non-coding sequences 0.5 kb (CNS-0.5) and 1 kb (CNS-1) upstream of <italic>Maf</italic> (red boxes). (<bold>B</bold>) Representative T-bet ChIP sequencing tracks across the <italic>Maf</italic> locus of Th1 cells (<xref ref-type="bibr" rid="bib17">Gökmen et al., 2013</xref>). Prominent T-bet binding peaks overlap with ATAC sequencing peaks within <italic>Maf</italic> CNS-0.5 and CNS-1 regions (red boxes). (<bold>C</bold>) T-bet and NF-κb binding motifs as defined by HOMER software (<xref ref-type="bibr" rid="bib19">Heinz et al., 2010</xref>). (<bold>D</bold>) In silico analysis identifies T-bet and NF-κb binding sites within <italic>Maf</italic> CNS-0.5 and CNS-1 regions (highlighted in blue). ATAC and ChIP sequencing tracks were visualized using the WashU browser from the Cistrome project (<xref ref-type="bibr" rid="bib33">Mei et al., 2017</xref>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-52549-fig3-figsupp1-v3.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title>Cytokine-mediated regulation of c-Maf and T-bet expression.</title><p>(<bold>A</bold>) Sort-purified siLP NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s from <italic>Rorc</italic><sup>Cre</sup> <italic>Maf</italic><sup>fl/fl</sup> or control mice were cultured in vitro for 36 hr in the presence of IL-7/SCF (w/o) or IL-7/SCF plus IL-1ß and IL-18. Subsequently, <italic>Ifng</italic> and <italic>Il22</italic> expression was measured by qPCR (n = 4, mean ± SEM, *p&lt;0.05). (<bold>B</bold>) Sort-purified siLP NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s from <italic>Rorc</italic><sup>Cre</sup> <italic>R26</italic><sup>EYFP</sup> mice were cultured in vitro for 36 hr in the presence of IL-7/SCF (w/o) or IL-7/SCF plus indicated cytokines. Subsequently, <italic>Maf</italic> expression was measured by qPCR (n = 4, mean ± SEM, *p&lt;0.05, **p&lt;0.01). (<bold>C</bold>) Protein expression of c-Maf by siLP NKp46<sup>+</sup> ILC3s isolated from <italic>Il12a</italic><sup>-/-</sup> or wild-type mice as measured by flow cytometry (pregated on viable Lin<sup>-</sup> CD127<sup>+</sup> cells). Representative flow cytometric profiles of RORγt vs. NKp46 expression (left); representative histograms showing c-Maf expression (middle); right, quantification of c-Maf gMFI (n = 3, mean ± SEM). (<bold>D–E</bold>) Sort-purified siLP NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s from <italic>Rorc</italic><sup>Cre</sup> <italic>R26</italic><sup>EYFP</sup> mice were cultured in vitro for 36 hr in the presence of IL-7/SCF (w/o) or IL-7/SCF plus indicated cytokines. Subsequently, <italic>Tbx21</italic> expression was measured by qPCR (n = 4, mean ± SEM, **p&lt;0.01, ***p&lt;0.001). The NF-κb inhibitor BMS-345541 (BMS) was added at 1 μM to the culture. (<bold>F</bold>) Sort-purified siLP NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s from <italic>Rorc</italic><sup>Cre</sup> <italic>Maf</italic><sup>fl/fl</sup> or control mice were cultured in vitro for 36 hr in the presence of IL-7/SCF (w/o) or IL-7/SCF plus IL-1ß and IL-18. Subsequently, <italic>Tbx21</italic> expression was measured by qPCR (n = 4, mean ± SEM, **p&lt;0.01). All in vitro data are pooled from two independent experiments each with two replicate wells.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-52549-fig3-figsupp2-v3.tif"/></fig><fig id="fig3s3" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 3.</label><caption><title>Notch signaling maintains NKp46 and c-Maf expression in NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s independent of cell proliferation.</title><p>(<bold>A</bold>) Small intestinal NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s were FACS-purified, labeled with a cell proliferation dye and cultured on OP9 or OP9-DLL1 feeder cells for 12 days. Representative dot plots show cell proliferation dye dilution (pre-gated on CCR6<sup>-</sup> ILC3s). Gates 1 to 4 indicate different generations of proliferating cells. (<bold>B</bold>) Representative contour plots showing NKp46 expression by distinct generations of OP9 or OP9-DLL1 cultured NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s (gates 1 to 4). (<bold>C</bold>) Quantitative comparison of c-Maf expression (gMFI) within different generations (gates 1 to 4) of OP9 vs. OP9-DLL1 cultured NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s (gates 1 to 4; n = 6, mean ± SEM, **p&lt;0.01, ***p&lt;0.001). Statistical differences were tested using an unpaired Students’ t-test (two-tailed).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-52549-fig3-figsupp3-v3.tif"/></fig></fig-group><p>In order to study the transcriptional activity of c-Maf at these sites, we cloned the <italic>Tbx21</italic> promoter alone or in conjunction with the <italic>Tbx21</italic> enhancer upstream of a luciferase reporter (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). Indeed, the <italic>Tbx21</italic> promoter showed strong transcriptional activity when compared to a promoterless control vector (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). The <italic>Tbx21</italic> enhancer further increased this activity when cloned upstream of the <italic>Tbx21</italic> promoter (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). Importantly, upon exogenous overexpression of c-Maf, we detected a strong de-repression of the reporter signal when we mutated the MARE sites within the <italic>Tbx21</italic> promoter (<xref ref-type="fig" rid="fig3">Figure 3B and E</xref>). Notably, mutating the <italic>Tbx21</italic> enhancer did not result in further increase of reporter activity, indicating that c-Maf facilitated its suppressive function mainly by acting on the <italic>Tbx21</italic> promoter (<xref ref-type="fig" rid="fig3">Figure 3B and E</xref>).</p><p>Thus, these data identified the <italic>Tbx21</italic> promoter as a c-Maf-responsive region through which c-Maf directly controls T-bet expression.</p></sec><sec id="s2-5"><title>c-Maf expression in CCR6<sup>-</sup> ILC3s is dependent on T-bet</title><p>Despite the fact that c-Maf acted as a direct repressor of T-bet, we observed strong correlation of c-Maf expression with T-bet expression in CCR6<sup>-</sup> ILC3s (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). This finding let us hypothesize that c-Maf expression was co-regulated with T-bet expression as part of the type one conversion program. To explore this hypothesis, we studied c-Maf expression in CCR6<sup>-</sup> ILC3s from T-bet-deficient mice. Indeed, in the absence of T-bet, c-Maf expression was strongly reduced when compared to T-bet-sufficient cells (<xref ref-type="fig" rid="fig3">Figure 3F</xref>), indicating that T-bet positively regulated its own repressor to establish an equilibrated state within the ILC3-to-ILC1 continuum.</p><p>In silico analysis of the <italic>Maf</italic> locus using ATAC-Seq (<xref ref-type="bibr" rid="bib51">Shih et al., 2016</xref>) and T-bet ChIP-Seq (<xref ref-type="bibr" rid="bib17">Gökmen et al., 2013</xref>) data further identified a striking overlap of T-bet binding peaks with open chromatin regions in NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s within two conserved non-coding sequences (CNS-0.5 and CNS-1) upstream of <italic>Maf</italic>, suggesting that T-bet directly controlled c-Maf expression in CCR6<sup>-</sup> ILC3s (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>).</p></sec><sec id="s2-6"><title>IL-1β- and IL-18-mediated NF-κb and Notch signalling promote c-Maf expression in CCR6<sup>-</sup> ILC3s</title><p>Next, we aimed to identify signals that control c-Maf expression in CCR6<sup>-</sup> ILC3s. Several cytokines were shown to regulate the differentiation and function of T-bet<sup>+</sup> CCR6<sup>-</sup> ILC3s, including IL-1ß, IL-12, IL-15, IL-18 and IL-23 (<xref ref-type="bibr" rid="bib27">Klose et al., 2013</xref>; <xref ref-type="bibr" rid="bib60">Vonarbourg et al., 2010</xref>; <xref ref-type="bibr" rid="bib5">Bernink et al., 2015</xref>; <xref ref-type="bibr" rid="bib47">Satoh-Takayama et al., 2010</xref>). Thus, we short-term stimulated sort-purified NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s with these cytokines in vitro and subsequently assessed their <italic>Maf</italic> expression by qPCR. Among all tested conditions, the pro-inflammatory IL-1 family cytokines IL-1ß and IL-18 stood out as potent inducers of <italic>Maf</italic> expression (<xref ref-type="fig" rid="fig3">Figure 3G</xref>). IL-1ß/IL-18 stimulation also induced <italic>Ifng</italic> and <italic>Il22</italic> expression (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2A</xref>). In fact, c-Maf-deficient NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s expressed more <italic>Ifng</italic> in response to IL-1ß/IL-18 as compared to controls (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2A</xref>), functionally connecting c-Maf expression downstream of these stimuli with the control of the type 1 effector response.</p><p>Since both IL-1ß and IL-18 signal via NF-κb and a conserved NF-κb binding site is present within CNS-0.5 upstream of <italic>Maf</italic> (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C and D</xref>), we hypothesized that NF-κb is involved in regulation of c-Maf expression downstream of IL-1ß/IL-18. Indeed, pharmacological inhibition of NF-κb signalling completely abrogated the cytokine-mediated induction of c-Maf expression (<xref ref-type="fig" rid="fig3">Figure 3H</xref>). In addition to IL-1ß/IL-18, we found that IL-12 suppressed <italic>Maf</italic> expression (<xref ref-type="fig" rid="fig3">Figure 3G</xref>). However, IL-12 did not interfere with the IL-1ß/IL-18-mediated c-Maf induction nor was c-Maf expression altered in NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s from <italic>Il12a</italic><sup>-/-</sup> mice as compared to controls (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2B and C</xref>), questioning a dominant role of IL-12 in c-Maf regulation.</p><p>Of note, the cytokine-mediated induction of <italic>Maf</italic> expression was accompanied by a concomitant decrease in <italic>Tbx21</italic> expression (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2D</xref>). Yet, this suppression was independent of NF-κb and c-Maf, since <italic>Tbx21</italic> expression was similarly suppressed by IL-1ß/IL-18 upon NF-κb inhibiton and in c-Maf-deficient NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2E and F</xref>). Taken together, these data demonstrate that, besides their reciprocal regulation, c-Maf and T-bet expression level are further critically controlled by cytokine signals.</p><p>In addition to cytokines, we also tested Notch signals as a potential extrinsic cue controlling both type 1 conversion of and c-Maf expression by ILC3s. Indeed, Notch was shown to be necessary for the induction and maintenance of T-bet and NKp46 expression in CCR6<sup>-</sup> ILC3s (<xref ref-type="bibr" rid="bib40">Rankin et al., 2013</xref>; <xref ref-type="bibr" rid="bib58">Viant et al., 2016</xref>). Similarly, we could recently identify Notch signalling as a potent inducer of c-Maf expression in T cells (<xref ref-type="bibr" rid="bib36">Neumann et al., 2019</xref>; <xref ref-type="bibr" rid="bib35">Neumann et al., 2014</xref>). To test the role of Notch we cultured purified NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s on OP9 or OP9-DLL1 stromal cells, the latter ectopically express the Notch ligand Delta-like 1 (DLL1). As reported earlier, Notch signals were essential to drive type 1 conversion of NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s, as evidenced by reduction and loss of NKp46 expression in the absence of Notch (<xref ref-type="fig" rid="fig3">Figure 3I</xref>). Importantly, c-Maf showed a similar expression pattern, being significantly reduced in NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s cultured on OP9 cells as compared to cells cultured on OP9-DLL1 cells (<xref ref-type="fig" rid="fig3">Figure 3J</xref>). This downregulation of NKp46 and c-Maf expression in the absence of continuous Notch signalling was independent of potential survival promoting effects of Notch (<xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3</xref>), establishing a molecular link between Notch signalling and type 1 conversion of NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s.</p></sec><sec id="s2-7"><title>Concluding remarks</title><p>Collectively, our study adds c-Maf as a novel key factor to the complex transcriptional network that governs the differentiation and function of ILC3s. In line with the emerging concept that co-expression and cross-regulation of multiple master regulators determines the fate and function of ILCs (<xref ref-type="bibr" rid="bib15">Fang and Zhu, 2017</xref>), we have uncovered an essential negative feedback loop between c-Maf and T-bet, which restrains the type 1 conversion of ILC3s. Given the antagonism between T-bet and RORγt, the c-Maf-dependent suppression of T-bet also indirectly stabilizes RORγt expression, thus preserving the type 3 identity of ILC3s. In addition, c-Maf may also directly contribute to RORγt expression in ILC3s, as it has been reported for T cells (<xref ref-type="bibr" rid="bib57">Tanaka et al., 2014</xref>; <xref ref-type="bibr" rid="bib67">Zuberbuehler et al., 2019</xref>). Our data supports and extends the findings of a very recent report that was released after completion of this manuscript (<xref ref-type="bibr" rid="bib37">Parker et al., 2020</xref>).</p></sec></sec><sec id="s3" sec-type="materials|methods"><title>Materials and methods</title><sec id="s3-1"><title>Animals</title><p>To generate conditional c-Maf-deficient mice, <italic>Rorc</italic><sup>Cre</sup> mice or <italic>Cd4</italic><sup>Cre</sup> mice were crossed to <italic>Maf</italic><sup>flox</sup> mice (provided by C. Birchmaier, MDC, Berlin, Germany) (<xref ref-type="bibr" rid="bib61">Wende et al., 2012</xref>). <italic>Cd4</italic><sup>Cre</sup> (<xref ref-type="bibr" rid="bib30">Lee et al., 2001</xref>), <italic>Rorc</italic><sup>Cre</sup> (<xref ref-type="bibr" rid="bib14">Eberl and Littman, 2004</xref>), <italic>R26</italic><sup>EYFP</sup> (<xref ref-type="bibr" rid="bib54">Srinivas et al., 2001</xref>) and T-bet-deficient mice (<xref ref-type="bibr" rid="bib56">Szabo et al., 2002</xref>) were described before. <italic>Il12a</italic><sup>-/-</sup> mice were kindly provided by U. Schleicher, Erlangen. All mice were on a C57BL/6 background and bred and maintained under specific pathogen-free conditions at our animal facilities (FEM Charité Berlin, Germany). All animal experiments were in accordance with the ethical standards of the institution or practice at which the studies were conducted and were reviewed and approved by the responsible ethics committees of Germany (LAGeSo Berlin, I C 113 – G0172/14) and Russia.</p></sec><sec id="s3-2"><title>Antibodies</title><p>A list of antibodies used in this study is provided in <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>.</p></sec><sec id="s3-3"><title>Cell isolation from small intestine and flow cytometry</title><p>Small intestinal tissue was treated with HBSS buffer (without calcium and magnesium) containing 5 mM EDTA and 10 mM HEPES (pH 7.5) at 37°C for 30 min to remove epithelial cells, minced and digested in HBSS buffer (with calcium and magnesium) containing 10 mM HEPES, 4% FCS, 0.5 mg/ml Collagenase D, 0.5 mg/ml DNaseI (Sigma), 0.5 U/ml Dispase (BD) with constantly stirring at 37°C for 30 min. The supernatant was filtered and the remaining tissue was mashed through a 70 μm mesh. siLP cells were separated using a 40%/80% step-gradient (Percoll solution, GE Healthcare). Flow cytometry was performed according to previously defined guidelines (<xref ref-type="bibr" rid="bib12">Cossarizza et al., 2019</xref>). In detail, single-cell suspensions were stained with different antibodies (<xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>). For cytokine analysis, cells were restimulated with PMA (Sigma, 10 ng/ml), ionomycin (Sigma, 1 μg/ml) and IL-23 (50 ng/ml) for 5 hr in TexMACS medium (Miltenyi Biotec) containing 10% FCS. After 1 hr of stimulation, Brefeldin A (Sigma, 5 μg/ml) was added to block cytokine secretion. For intracellular staining of cytokines and transcription factors, cells were first stained for surface markers and dead cells were labeled with Fixable Viability Dye eFluor780 (eBioscience). After that, cells were fixed in Fix/Perm buffer (eBioscience) at 4°C for 1 hr, followed by permeabilization (eBioscience) at 4°C for 2 hr in the presence of antibodies. Cells were acquired with a BD LSRFortessa X-20 and analysis was performed with FlowJo (Tree Star) software.</p></sec><sec id="s3-4"><title>RNA-seq analysis</title><p>NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s and CCR6<sup>+</sup> ILC3s were sorted from the siLP of 8–12 weeks old <italic>Rorc</italic><sup>Cre</sup> <italic>Maf</italic><sup>fl/fl</sup> or littermate <italic>Maf</italic><sup>fl/fl</sup> control mice using a BD FACSAria sorter (sorting strategy <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2A</xref>). RNA was isolated with the RNeasy Micro kit from Qiagen according to the manufacturer`s protocol. RNA libraries were prepared using the Smart-Seq V4 Ultra low Input RNA kit (Takara Clontech). Sequencing was performed on an Illumina Nextseq 500 generating 75 bp paired-end reads. Three biological replicates of each subset were sequenced. Raw sequence reads were mapped to the mouse GRCm38/mm10 genome with TopHat2 (<xref ref-type="bibr" rid="bib26">Kim et al., 2013</xref>) in very-sensitive settings for Bowtie2 (<xref ref-type="bibr" rid="bib29">Langmead and Salzberg, 2012</xref>). Gene expression was quantified either by HTSeq (<xref ref-type="bibr" rid="bib2">Anders et al., 2015</xref>) for total RNA or featureCounts (<xref ref-type="bibr" rid="bib31">Liao et al., 2014</xref>) for mRNA and analyzed using DESeq2 (<xref ref-type="bibr" rid="bib32">Love et al., 2014</xref>). A cut-off (FC &gt; 1.5 and p-value &lt; 0.05) was applied for calling differentially expressed genes. Furthermore, differentially expressed genes were filtered for ‘gene_type = protein_coding’ before further analysis.</p></sec><sec id="s3-5"><title>Gene set enrichment analysis (GSEA)</title><p>GSEA was performed using the GSEA tool from the Broad Institute. Gene sets used in this study were generated by taking the top upregulated genes (log<sub>2</sub>FC &gt; 2) from published differential gene expression analysis of RNA-seq data comparing ILC1s or NK cells with CCR6<sup>-</sup> ILC3s (<xref ref-type="bibr" rid="bib38">Pokrovskii et al., 2019</xref>).</p></sec><sec id="s3-6"><title>Luciferase reporter assay</title><p>HEK293T cells were transfected with the pGL3 basic luciferase plasmid (Promega) containing the T-bet promoter alone or the T-bet promoter in combination with an upstream enhancer region (<xref ref-type="bibr" rid="bib64">Yang et al., 2007</xref>), or the empty pGL3 basic in combination with an internal control pRL-TK Renilla plasmid (Promega). The T-bet enhancer/promoter plasmid was described before (<xref ref-type="bibr" rid="bib22">Hosokawa et al., 2013</xref>) and kindly provided by H. Hosokawa (Tokai University, Japan). In order to assess gene regulation by c-Maf, putative <italic>Maf</italic> responsive elements in the promoter and enhancer were mutated using the Q5 Site-Directed Mutagenesis Kit (New England Biolabs). In addition to mutated reporter plasmids, cells were co-transfected with c-Maf coding sequence in pMSCV. Luciferase activity was measured on a SpectraMax i33 microplate reader (Molecular Devices) after 24 hr using dual luciferase assay system (Promega). Luciferase activity was determined relative to Renilla.</p></sec><sec id="s3-7"><title>In vitro stimulation of NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s with cytokines</title><p>CD45<sup>+</sup> Lineage<sup>-</sup> (Lineage: anti-CD19, anti-Gr-1, anti-CD3, anti-CD5) RORγt<sup>fm+</sup> CD127<sup>+</sup> NKp46<sup>+</sup> CCR6<sup>-</sup> cells were sort-purified from the siLP of 11–14 week old <italic>Rorc</italic><sup>Cre</sup> <italic>R26</italic><sup>EYFP</sup> mice. Sorted cells were transferred in complete RPMI medium to a 96 U bottom well plate at a density of 15.000 cells/well. Subsequently cells were cultured in the presence of IL-7 (20 ng/ml) and SCF (20 ng/ml) plus different cytokines (IL-1ß, IL-12, IL-15, IL-18, IL-23; each at 20 ng/ml) for 36 hr before mRNA analysis. For blocking NF-κb activation, BMS-345541, a selective inhibitor of IκB kinase (<xref ref-type="bibr" rid="bib7">Burke et al., 2003</xref>), was added at a concentration of 1 μM to the culture.</p></sec><sec id="s3-8"><title>In vitro culture of NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s on OP9-DLL1 cells</title><p>CD45<sup>+</sup> Lineage<sup>-</sup> (Lineage: anti-CD19, anti-Gr-1, anti-CD3, anti-CD5) RORγt<sup>fm+</sup> CD127<sup>+</sup> NKp46<sup>+</sup> CCR6<sup>-</sup> cells were sort-purified from the siLP of 11–14 week old <italic>Rorc</italic><sup>Cre</sup> <italic>R26</italic><sup>EYFP</sup> mice. Sorted cells were transferred in complete RPMI medium to OP9 or OP9-DLL1 cells at a density of 10.000 cells/well and cultured in the presence of IL-7 (20 ng/ml) and SCF (20 ng/ml) for 12 days before flow cytometric analysis. OP9 cells are murine stromal cells derived from OP/OP mice used as feeder cells in lymphocyte differentiation assays. OP9-DLL1 cells are transfected with Notch ligand delta-like-1 (<xref ref-type="bibr" rid="bib49">Schmitt and Zúñiga-Pflücker, 2002</xref>). Prior to adding isolated lymphocytes, confluent feeder cells were treated with 5 μg/ml Mitomycin C (Sigma) for 3 hr at 37°C and subsequently seeded on a 96 flat bottom well plate at a density of 50.000 cells/well.</p></sec><sec id="s3-9"><title>Bone marrow chimeras</title><p>Bone marrow cells from wild-type CD45.1<sup>+</sup> CD90.2<sup>+</sup> C57BL/6 and CD45.2<sup>+</sup> CD90.2<sup>+</sup> <italic>Rorc</italic><sup>Cre</sup> <italic>Maf</italic><sup>fl/fl</sup> mice were mixed in a 1:1 ratio and intravenously injected into sub-lethally irradiated CD90.1<sup>+</sup> wild-type recipient mice. Small and colonic lamina propria of reconstituted mice were analysed 6 weeks after cell transfer.</p></sec><sec id="s3-10"><title>qPCR</title><p>mRNA for real-time qPCR was isolated with the RNeasy Plus Micro Kit according to the manual of the manufacturer (QIAGEN). Reverse transcription was done with the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems) as it is described in the manufacturer’s protocol. qPCR was performed using a Quant Studio five system (Applied Biosystems) and the SYBR Green PCR Master Mix Kit (Applied Biosystems). The mRNA expression is presented relative to the expression of the housekeeping gene hypoxanthine-guanine phosphoribosyl-transferase (HPRT). Real-time qPCR primer can be found in <xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>.</p></sec><sec id="s3-11"><title>Statistical analysis</title><p>Data are the mean with SEM and summarize or are representative of independent experiments as specified in the text. Statistical analyses were performed using Prism software (GraphPad) with two-tailed unpaired Student's <italic>t</italic> test (except RNA-seq data).</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>This research was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) Priority Program 1937 ‘Innate Lymphoid Cells’ (to CN project number: 428192857 and to AD project number: DI764/9-2). FH and MFM were supported by the state of Berlin and the ‘European Regional Development Fund’ (ERDF 2014–2020, EFRE 1.8/11, Deutsches Rheuma‐Forschungszentrum). We acknowledge support from the DFG and the Open Access Publication Funds of Charité – Universitätsmedizin Berlin. We thank Irene Mattiola, Christoph S N Klose, Fabian Guendel-Rojas, Mario Witkowski, Pawel Durek and Katrin Lehmann for discussion, technical and experimental help and proofreading of the manuscript.</p></ack><sec id="s4" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Data curation, Formal analysis, Validation, Investigation, Methodology, Designed and performed experiments, Analysed data</p></fn><fn fn-type="con" id="con2"><p>Data curation, Formal analysis, Validation, Investigation, Methodology, Designed and performed experiments, Analysed data</p></fn><fn fn-type="con" id="con3"><p>Formal analysis, Validation, Investigation, Methodology, Designed and performed experiments, Analysed data</p></fn><fn fn-type="con" id="con4"><p>Formal analysis, Methodology, Performed experiments, Analysed data</p></fn><fn fn-type="con" id="con5"><p>Methodology, Provided discussion, Proofread the manuscript</p></fn><fn fn-type="con" id="con6"><p>Formal analysis, Methodology, Performed computational analyses of 16S rRNA-seq data</p></fn><fn fn-type="con" id="con7"><p>Resources, Supervision, Supervised sequencing experiments, Provided reagents and equipment for their execution</p></fn><fn fn-type="con" id="con8"><p>Resources, Methodology, Assisted in chimera experiments</p></fn><fn fn-type="con" id="con9"><p>Conceptualization, Resources, Supervision, Funding acquisition, Provided crucial reagents, Contributed to the design of the study, Proofread the manuscript</p></fn><fn fn-type="con" id="con10"><p>Conceptualization, Resources, Data curation, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Methodology, Project administration, Conceived the project, Designed and performed most experiments, Analysed the data, Generated the figures and wrote the manuscript with the input of all co-authors</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other" id="fn1"><p>All animal experiments were in accordance with the ethical standards of the institution or practice at which the studies were conducted and were reviewed and approved by the responsible ethics committees of Germany (LAGeSo Berlin, I C 113 – G0172/14) and Russia.</p></fn></fn-group></sec><sec id="s5" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Differentially expressed genes between c-Maf-deficient and -sufficient NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s.</title><p>NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s were sorted from siLP of <italic>Rorc</italic><sup>Cre</sup><italic>Maf</italic><sup>fl/fl</sup> and control mice and subjected to RNA sequencing. 941 genes were identified as differentially expressed (FC &gt;1.5, p-value&lt;0.05). Data represent the combined analysis of three biologically independent samples.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-52549-supp1-v3.xlsx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>Genes differentially expressed in c-Maf-deficient NKp46<sup>+</sup> CCR6<sup>-</sup> and NKp46<sup>-</sup> CCR6<sup>+</sup> ILC3s.</title><p>NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s and NKp46<sup>-</sup> CCR6<sup>+</sup> ILC3s were sorted from siLP of <italic>Rorc</italic><sup>Cre</sup><italic>Maf</italic><sup>fl/fl</sup> and control mice and subjected to RNA sequencing. 294 genes were found to be differentially expressed (FC &gt;1.5, p-value&lt;0.05) in both subsets.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-52549-supp2-v3.xlsx"/></supplementary-material><supplementary-material id="supp3"><label>Supplementary file 3.</label><caption><title>List of antibodies used in this study.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-52549-supp3-v3.xlsx"/></supplementary-material><supplementary-material id="supp4"><label>Supplementary file 4.</label><caption><title>qPCR Primer used in this study.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-52549-supp4-v3.xlsx"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="pdf" mimetype="application" xlink:href="elife-52549-transrepform-v3.pdf"/></supplementary-material></sec><sec id="s6" sec-type="data-availability"><title>Data availability</title><p>Sequencing data supporting the findings of this study have been deposited in the Gene Expression Omnibus (GEO) database under the GEO accession number: RNA-Seq: GSE143867.</p><p>The following dataset was generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Caroline</surname><given-names>Tizian</given-names></name><name><surname>Annette</surname><given-names>Lahmann</given-names></name><name><surname>Oliver</surname><given-names>Hölsken</given-names></name><name><surname>Catalina</surname><given-names>Cosovanu</given-names></name><name><surname>Michael</surname><given-names>Kofoed-Branzk</given-names></name><name><surname>Frederik</surname><given-names>Heinrich</given-names></name><name><surname>Mir-Farzin</surname><given-names>Mashreghi</given-names></name><name><surname>Andrey</surname><given-names>Kruglov</given-names></name><name><surname>Andreas</surname><given-names>Diefenbach</given-names></name><name><surname>Christian</surname><given-names>Neuman</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>c-Maf restrains T-bet-driven programming of CCR6-negative group 3 innate lymphoid cells</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE143867">GSE143867</pub-id></element-citation></p><p>The following previously published datasets were used:</p><p><element-citation id="dataset2" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Pokrovskii</surname><given-names>M</given-names></name><name><surname>Hall</surname><given-names>JA</given-names></name><name><surname>Ochayon</surname><given-names>DE</given-names></name><name><surname>Yi</surname><given-names>R</given-names></name><name><surname>Chaimowitz</surname><given-names>NS</given-names></name><name><surname>Seelamneni</surname><given-names>H</given-names></name><name><surname>Carriero</surname><given-names>N</given-names></name><name><surname>Watters</surname><given-names>A</given-names></name><name><surname>Waggoner</surname><given-names>SN</given-names></name><name><surname>Littman</surname><given-names>DR</given-names></name><name><surname>Bonneau</surname><given-names>R</given-names></name><name><surname>Miraldi</surname><given-names>ER</given-names></name></person-group><year iso-8601-date="2019">2019</year><data-title>Gene expression (RNA-seq) of innate lymphoid cells of the small intestine (SI) and large intestine (LI) lamina propria</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE116092">GSE116092</pub-id></element-citation></p><p><element-citation id="dataset3" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Gökmen</surname><given-names>MR</given-names></name><name><surname>Dong</surname><given-names>R</given-names></name><name><surname>Kanhere</surname><given-names>A</given-names></name><name><surname>Powell</surname><given-names>N</given-names></name><name><surname>Perucha</surname><given-names>E</given-names></name><name><surname>Jackson</surname><given-names>I</given-names></name><name><surname>Howard</surname><given-names>JK</given-names></name><name><surname>Hernandez-Fuentes</surname><given-names>M</given-names></name><name><surname>Jenner</surname><given-names>RG</given-names></name><name><surname>Lord</surname><given-names>GM</given-names></name></person-group><year iso-8601-date="2013">2013</year><data-title>ChIP-seq analysis of T-bet in WT mice (Th1 cells)</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE77695">GSE40623</pub-id></element-citation></p><p><element-citation id="dataset4" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Shih</surname><given-names>HY</given-names></name><name><surname>Sciumè</surname><given-names>G</given-names></name><name><surname>Mikami</surname><given-names>Y</given-names></name><name><surname>Guo</surname><given-names>L</given-names></name><name><surname>Sun</surname><given-names>HW</given-names></name><name><surname>Brooks</surname><given-names>SR</given-names></name><name><surname>Urban</surname><given-names>JF Jr</given-names></name><name><surname>Davis</surname><given-names>FP</given-names></name><name><surname>Kanno</surname><given-names>Y</given-names></name><name><surname>O'Shea</surname><given-names>JJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><data-title>Integrated analysis of epigenome and transcriptome data from innate lymphoid cells and their progenitors</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE77695">GSE77695</pub-id></element-citation></p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname> <given-names>NM</given-names></name><name><surname>Lau</surname> <given-names>CM</given-names></name><name><surname>Fan</surname> <given-names>X</given-names></name><name><surname>Rapp</surname> <given-names>M</given-names></name><name><surname>Geary</surname> <given-names>CD</given-names></name><name><surname>Weizman</surname> <given-names>OE</given-names></name><name><surname>Diaz-Salazar</surname> <given-names>C</given-names></name><name><surname>Sun</surname> <given-names>JC</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Transcription factor IRF8 orchestrates the adaptive natural killer cell response</article-title><source>Immunity</source><volume>48</volume><fpage>1172</fpage><lpage>1182</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2018.04.018</pub-id><pub-id pub-id-type="pmid">29858012</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anders</surname> <given-names>S</given-names></name><name><surname>Pyl</surname> <given-names>PT</given-names></name><name><surname>Huber</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>HTSeq--a Python framework to work with high-throughput sequencing data</article-title><source>Bioinformatics</source><volume>31</volume><fpage>166</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btu638</pub-id><pub-id pub-id-type="pmid">25260700</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aschenbrenner</surname> <given-names>D</given-names></name><name><surname>Foglierini</surname> <given-names>M</given-names></name><name><surname>Jarrossay</surname> <given-names>D</given-names></name><name><surname>Hu</surname> <given-names>D</given-names></name><name><surname>Weiner</surname> <given-names>HL</given-names></name><name><surname>Kuchroo</surname> <given-names>VK</given-names></name><name><surname>Lanzavecchia</surname> <given-names>A</given-names></name><name><surname>Notarbartolo</surname> <given-names>S</given-names></name><name><surname>Sallusto</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>An immunoregulatory and tissue-residency program modulated by c-MAF in human T<sub>H</sub>17 cells</article-title><source>Nature Immunology</source><volume>19</volume><fpage>1126</fpage><lpage>1136</lpage><pub-id pub-id-type="doi">10.1038/s41590-018-0200-5</pub-id><pub-id pub-id-type="pmid">30201991</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernink</surname> <given-names>JH</given-names></name><name><surname>Peters</surname> <given-names>CP</given-names></name><name><surname>Munneke</surname> <given-names>M</given-names></name><name><surname>te Velde</surname> <given-names>AA</given-names></name><name><surname>Meijer</surname> <given-names>SL</given-names></name><name><surname>Weijer</surname> <given-names>K</given-names></name><name><surname>Hreggvidsdottir</surname> <given-names>HS</given-names></name><name><surname>Heinsbroek</surname> <given-names>SE</given-names></name><name><surname>Legrand</surname> <given-names>N</given-names></name><name><surname>Buskens</surname> <given-names>CJ</given-names></name><name><surname>Bemelman</surname> <given-names>WA</given-names></name><name><surname>Mjösberg</surname> <given-names>JM</given-names></name><name><surname>Spits</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues</article-title><source>Nature Immunology</source><volume>14</volume><fpage>221</fpage><lpage>229</lpage><pub-id pub-id-type="doi">10.1038/ni.2534</pub-id><pub-id pub-id-type="pmid">23334791</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernink</surname> <given-names>JH</given-names></name><name><surname>Krabbendam</surname> <given-names>L</given-names></name><name><surname>Germar</surname> <given-names>K</given-names></name><name><surname>de Jong</surname> <given-names>E</given-names></name><name><surname>Gronke</surname> <given-names>K</given-names></name><name><surname>Kofoed-Nielsen</surname> <given-names>M</given-names></name><name><surname>Munneke</surname> <given-names>JM</given-names></name><name><surname>Hazenberg</surname> <given-names>MD</given-names></name><name><surname>Villaudy</surname> <given-names>J</given-names></name><name><surname>Buskens</surname> <given-names>CJ</given-names></name><name><surname>Bemelman</surname> <given-names>WA</given-names></name><name><surname>Diefenbach</surname> <given-names>A</given-names></name><name><surname>Blom</surname> <given-names>B</given-names></name><name><surname>Spits</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Interleukin-12 and -23 control plasticity of CD127+ group 1 and group 3 innate lymphoid cells in the intestinal Lamina propria</article-title><source>Immunity</source><volume>43</volume><fpage>146</fpage><lpage>160</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2015.06.019</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buonocore</surname> <given-names>S</given-names></name><name><surname>Ahern</surname> <given-names>PP</given-names></name><name><surname>Uhlig</surname> <given-names>HH</given-names></name><name><surname>Ivanov</surname> <given-names>II</given-names></name><name><surname>Littman</surname> <given-names>DR</given-names></name><name><surname>Maloy</surname> <given-names>KJ</given-names></name><name><surname>Powrie</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology</article-title><source>Nature</source><volume>464</volume><fpage>1371</fpage><lpage>1375</lpage><pub-id pub-id-type="doi">10.1038/nature08949</pub-id><pub-id pub-id-type="pmid">20393462</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burke</surname> <given-names>JR</given-names></name><name><surname>Pattoli</surname> <given-names>MA</given-names></name><name><surname>Gregor</surname> <given-names>KR</given-names></name><name><surname>Brassil</surname> <given-names>PJ</given-names></name><name><surname>MacMaster</surname> <given-names>JF</given-names></name><name><surname>McIntyre</surname> <given-names>KW</given-names></name><name><surname>Yang</surname> <given-names>X</given-names></name><name><surname>Iotzova</surname> <given-names>VS</given-names></name><name><surname>Clarke</surname> <given-names>W</given-names></name><name><surname>Strnad</surname> <given-names>J</given-names></name><name><surname>Qiu</surname> <given-names>Y</given-names></name><name><surname>Zusi</surname> <given-names>FC</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>BMS-345541 is a highly selective inhibitor of I kappa B kinase that binds at an allosteric site of the enzyme and blocks NF-kappa B-dependent transcription in mice</article-title><source>Journal of Biological Chemistry</source><volume>278</volume><fpage>1450</fpage><lpage>1456</lpage><pub-id pub-id-type="doi">10.1074/jbc.M209677200</pub-id><pub-id pub-id-type="pmid">12403772</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cella</surname> <given-names>M</given-names></name><name><surname>Gamini</surname> <given-names>R</given-names></name><name><surname>Sécca</surname> <given-names>C</given-names></name><name><surname>Collins</surname> <given-names>PL</given-names></name><name><surname>Zhao</surname> <given-names>S</given-names></name><name><surname>Peng</surname> <given-names>V</given-names></name><name><surname>Robinette</surname> <given-names>ML</given-names></name><name><surname>Schettini</surname> <given-names>J</given-names></name><name><surname>Zaitsev</surname> <given-names>K</given-names></name><name><surname>Gordon</surname> <given-names>W</given-names></name><name><surname>Bando</surname> <given-names>JK</given-names></name><name><surname>Yomogida</surname> <given-names>K</given-names></name><name><surname>Cortez</surname> <given-names>V</given-names></name><name><surname>Fronick</surname> <given-names>C</given-names></name><name><surname>Fulton</surname> <given-names>R</given-names></name><name><surname>Lin</surname> <given-names>LL</given-names></name><name><surname>Gilfillan</surname> <given-names>S</given-names></name><name><surname>Flavell</surname> <given-names>RA</given-names></name><name><surname>Shan</surname> <given-names>L</given-names></name><name><surname>Artyomov</surname> <given-names>MN</given-names></name><name><surname>Bowman</surname> <given-names>M</given-names></name><name><surname>Oltz</surname> <given-names>EM</given-names></name><name><surname>Jelinsky</surname> <given-names>SA</given-names></name><name><surname>Colonna</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Subsets of ILC3-ILC1-like cells generate a diversity spectrum of innate lymphoid cells in human mucosal tissues</article-title><source>Nature Immunology</source><volume>20</volume><fpage>980</fpage><lpage>991</lpage><pub-id pub-id-type="doi">10.1038/s41590-019-0425-y</pub-id><pub-id pub-id-type="pmid">31209406</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chea</surname> <given-names>S</given-names></name><name><surname>Perchet</surname> <given-names>T</given-names></name><name><surname>Petit</surname> <given-names>M</given-names></name><name><surname>Verrier</surname> <given-names>T</given-names></name><name><surname>Guy-Grand</surname> <given-names>D</given-names></name><name><surname>Banchi</surname> <given-names>EG</given-names></name><name><surname>Vosshenrich</surname> <given-names>CA</given-names></name><name><surname>Di Santo</surname> <given-names>JP</given-names></name><name><surname>Cumano</surname> <given-names>A</given-names></name><name><surname>Golub</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Notch signaling in group 3 innate lymphoid cells modulates their plasticity</article-title><source>Science Signaling</source><volume>9</volume><elocation-id>ra45</elocation-id><pub-id pub-id-type="doi">10.1126/scisignal.aaf2223</pub-id><pub-id pub-id-type="pmid">27141929</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ciofani</surname> <given-names>M</given-names></name><name><surname>Madar</surname> <given-names>A</given-names></name><name><surname>Galan</surname> <given-names>C</given-names></name><name><surname>Sellars</surname> <given-names>M</given-names></name><name><surname>Mace</surname> <given-names>K</given-names></name><name><surname>Pauli</surname> <given-names>F</given-names></name><name><surname>Agarwal</surname> <given-names>A</given-names></name><name><surname>Huang</surname> <given-names>W</given-names></name><name><surname>Parkhurst</surname> <given-names>CN</given-names></name><name><surname>Muratet</surname> <given-names>M</given-names></name><name><surname>Newberry</surname> <given-names>KM</given-names></name><name><surname>Meadows</surname> <given-names>S</given-names></name><name><surname>Greenfield</surname> <given-names>A</given-names></name><name><surname>Yang</surname> <given-names>Y</given-names></name><name><surname>Jain</surname> <given-names>P</given-names></name><name><surname>Kirigin</surname> <given-names>FK</given-names></name><name><surname>Birchmeier</surname> <given-names>C</given-names></name><name><surname>Wagner</surname> <given-names>EF</given-names></name><name><surname>Murphy</surname> <given-names>KM</given-names></name><name><surname>Myers</surname> <given-names>RM</given-names></name><name><surname>Bonneau</surname> <given-names>R</given-names></name><name><surname>Littman</surname> <given-names>DR</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>A validated regulatory network for Th17 cell specification</article-title><source>Cell</source><volume>151</volume><fpage>289</fpage><lpage>303</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2012.09.016</pub-id><pub-id pub-id-type="pmid">23021777</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cortez</surname> <given-names>VS</given-names></name><name><surname>Colonna</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Diversity and function of group 1 innate lymphoid cells</article-title><source>Immunology Letters</source><volume>179</volume><fpage>19</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1016/j.imlet.2016.07.005</pub-id><pub-id pub-id-type="pmid">27394699</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cossarizza</surname> <given-names>A</given-names></name><name><surname>Chang</surname> <given-names>HD</given-names></name><name><surname>Radbruch</surname> <given-names>A</given-names></name><name><surname>Acs</surname> <given-names>A</given-names></name><name><surname>Adam</surname> <given-names>D</given-names></name><name><surname>Adam-Klages</surname> <given-names>S</given-names></name><name><surname>Agace</surname> <given-names>WW</given-names></name><name><surname>Aghaeepour</surname> <given-names>N</given-names></name><name><surname>Akdis</surname> <given-names>M</given-names></name><name><surname>Allez</surname> <given-names>M</given-names></name><name><surname>Almeida</surname> <given-names>LN</given-names></name><name><surname>Alvisi</surname> <given-names>G</given-names></name><name><surname>Anderson</surname> <given-names>G</given-names></name><name><surname>Andrä</surname> <given-names>I</given-names></name><name><surname>Annunziato</surname> <given-names>F</given-names></name><name><surname>Anselmo</surname> <given-names>A</given-names></name><name><surname>Bacher</surname> <given-names>P</given-names></name><name><surname>Baldari</surname> <given-names>CT</given-names></name><name><surname>Bari</surname> <given-names>S</given-names></name><name><surname>Barnaba</surname> <given-names>V</given-names></name><name><surname>Barros-Martins</surname> <given-names>J</given-names></name><name><surname>Battistini</surname> <given-names>L</given-names></name><name><surname>Bauer</surname> <given-names>W</given-names></name><name><surname>Baumgart</surname> <given-names>S</given-names></name><name><surname>Baumgarth</surname> <given-names>N</given-names></name><name><surname>Baumjohann</surname> <given-names>D</given-names></name><name><surname>Baying</surname> <given-names>B</given-names></name><name><surname>Bebawy</surname> <given-names>M</given-names></name><name><surname>Becher</surname> <given-names>B</given-names></name><name><surname>Beisker</surname> <given-names>W</given-names></name><name><surname>Benes</surname> <given-names>V</given-names></name><name><surname>Beyaert</surname> <given-names>R</given-names></name><name><surname>Blanco</surname> <given-names>A</given-names></name><name><surname>Boardman</surname> <given-names>DA</given-names></name><name><surname>Bogdan</surname> <given-names>C</given-names></name><name><surname>Borger</surname> <given-names>JG</given-names></name><name><surname>Borsellino</surname> <given-names>G</given-names></name><name><surname>Boulais</surname> <given-names>PE</given-names></name><name><surname>Bradford</surname> <given-names>JA</given-names></name><name><surname>Brenner</surname> <given-names>D</given-names></name><name><surname>Brinkman</surname> <given-names>RR</given-names></name><name><surname>Brooks</surname> <given-names>AES</given-names></name><name><surname>Busch</surname> <given-names>DH</given-names></name><name><surname>Büscher</surname> <given-names>M</given-names></name><name><surname>Bushnell</surname> <given-names>TP</given-names></name><name><surname>Calzetti</surname> <given-names>F</given-names></name><name><surname>Cameron</surname> <given-names>G</given-names></name><name><surname>Cammarata</surname> <given-names>I</given-names></name><name><surname>Cao</surname> <given-names>X</given-names></name><name><surname>Cardell</surname> <given-names>SL</given-names></name><name><surname>Casola</surname> <given-names>S</given-names></name><name><surname>Cassatella</surname> <given-names>MA</given-names></name><name><surname>Cavani</surname> <given-names>A</given-names></name><name><surname>Celada</surname> <given-names>A</given-names></name><name><surname>Chatenoud</surname> <given-names>L</given-names></name><name><surname>Chattopadhyay</surname> <given-names>PK</given-names></name><name><surname>Chow</surname> <given-names>S</given-names></name><name><surname>Christakou</surname> <given-names>E</given-names></name><name><surname>Čičin-Šain</surname> <given-names>L</given-names></name><name><surname>Clerici</surname> <given-names>M</given-names></name><name><surname>Colombo</surname> <given-names>FS</given-names></name><name><surname>Cook</surname> <given-names>L</given-names></name><name><surname>Cooke</surname> <given-names>A</given-names></name><name><surname>Cooper</surname> <given-names>AM</given-names></name><name><surname>Corbett</surname> <given-names>AJ</given-names></name><name><surname>Cosma</surname> <given-names>A</given-names></name><name><surname>Cosmi</surname> <given-names>L</given-names></name><name><surname>Coulie</surname> <given-names>PG</given-names></name><name><surname>Cumano</surname> <given-names>A</given-names></name><name><surname>Cvetkovic</surname> <given-names>L</given-names></name><name><surname>Dang</surname> <given-names>VD</given-names></name><name><surname>Dang-Heine</surname> <given-names>C</given-names></name><name><surname>Davey</surname> <given-names>MS</given-names></name><name><surname>Davies</surname> <given-names>D</given-names></name><name><surname>De Biasi</surname> <given-names>S</given-names></name><name><surname>Del Zotto</surname> <given-names>G</given-names></name><name><surname>Dela Cruz</surname> <given-names>GV</given-names></name><name><surname>Delacher</surname> <given-names>M</given-names></name><name><surname>Della Bella</surname> <given-names>S</given-names></name><name><surname>Dellabona</surname> <given-names>P</given-names></name><name><surname>Deniz</surname> <given-names>G</given-names></name><name><surname>Dessing</surname> <given-names>M</given-names></name><name><surname>Di Santo</surname> <given-names>JP</given-names></name><name><surname>Diefenbach</surname> <given-names>A</given-names></name><name><surname>Dieli</surname> <given-names>F</given-names></name><name><surname>Dolf</surname> <given-names>A</given-names></name><name><surname>Dörner</surname> <given-names>T</given-names></name><name><surname>Dress</surname> <given-names>RJ</given-names></name><name><surname>Dudziak</surname> <given-names>D</given-names></name><name><surname>Dustin</surname> <given-names>M</given-names></name><name><surname>Dutertre</surname> <given-names>CA</given-names></name><name><surname>Ebner</surname> <given-names>F</given-names></name><name><surname>Eckle</surname> <given-names>SBG</given-names></name><name><surname>Edinger</surname> <given-names>M</given-names></name><name><surname>Eede</surname> <given-names>P</given-names></name><name><surname>Ehrhardt</surname> <given-names>GRA</given-names></name><name><surname>Eich</surname> <given-names>M</given-names></name><name><surname>Engel</surname> <given-names>P</given-names></name><name><surname>Engelhardt</surname> <given-names>B</given-names></name><name><surname>Erdei</surname> <given-names>A</given-names></name><name><surname>Esser</surname> <given-names>C</given-names></name><name><surname>Everts</surname> <given-names>B</given-names></name><name><surname>Evrard</surname> <given-names>M</given-names></name><name><surname>Falk</surname> <given-names>CS</given-names></name><name><surname>Fehniger</surname> <given-names>TA</given-names></name><name><surname>Felipo-Benavent</surname> <given-names>M</given-names></name><name><surname>Ferry</surname> <given-names>H</given-names></name><name><surname>Feuerer</surname> <given-names>M</given-names></name><name><surname>Filby</surname> <given-names>A</given-names></name><name><surname>Filkor</surname> <given-names>K</given-names></name><name><surname>Fillatreau</surname> <given-names>S</given-names></name><name><surname>Follo</surname> <given-names>M</given-names></name><name><surname>Förster</surname> <given-names>I</given-names></name><name><surname>Foster</surname> <given-names>J</given-names></name><name><surname>Foulds</surname> <given-names>GA</given-names></name><name><surname>Frehse</surname> <given-names>B</given-names></name><name><surname>Frenette</surname> <given-names>PS</given-names></name><name><surname>Frischbutter</surname> <given-names>S</given-names></name><name><surname>Fritzsche</surname> <given-names>W</given-names></name><name><surname>Galbraith</surname> <given-names>DW</given-names></name><name><surname>Gangaev</surname> <given-names>A</given-names></name><name><surname>Garbi</surname> <given-names>N</given-names></name><name><surname>Gaudilliere</surname> <given-names>B</given-names></name><name><surname>Gazzinelli</surname> <given-names>RT</given-names></name><name><surname>Geginat</surname> <given-names>J</given-names></name><name><surname>Gerner</surname> <given-names>W</given-names></name><name><surname>Gherardin</surname> <given-names>NA</given-names></name><name><surname>Ghoreschi</surname> <given-names>K</given-names></name><name><surname>Gibellini</surname> <given-names>L</given-names></name><name><surname>Ginhoux</surname> <given-names>F</given-names></name><name><surname>Goda</surname> <given-names>K</given-names></name><name><surname>Godfrey</surname> <given-names>DI</given-names></name><name><surname>Goettlinger</surname> <given-names>C</given-names></name><name><surname>González-Navajas</surname> <given-names>JM</given-names></name><name><surname>Goodyear</surname> <given-names>CS</given-names></name><name><surname>Gori</surname> <given-names>A</given-names></name><name><surname>Grogan</surname> <given-names>JL</given-names></name><name><surname>Grummitt</surname> <given-names>D</given-names></name><name><surname>Grützkau</surname> <given-names>A</given-names></name><name><surname>Haftmann</surname> <given-names>C</given-names></name><name><surname>Hahn</surname> <given-names>J</given-names></name><name><surname>Hammad</surname> <given-names>H</given-names></name><name><surname>Hämmerling</surname> <given-names>G</given-names></name><name><surname>Hansmann</surname> <given-names>L</given-names></name><name><surname>Hansson</surname> <given-names>G</given-names></name><name><surname>Harpur</surname> <given-names>CM</given-names></name><name><surname>Hartmann</surname> <given-names>S</given-names></name><name><surname>Hauser</surname> <given-names>A</given-names></name><name><surname>Hauser</surname> <given-names>AE</given-names></name><name><surname>Haviland</surname> <given-names>DL</given-names></name><name><surname>Hedley</surname> <given-names>D</given-names></name><name><surname>Hernández</surname> <given-names>DC</given-names></name><name><surname>Herrera</surname> <given-names>G</given-names></name><name><surname>Herrmann</surname> <given-names>M</given-names></name><name><surname>Hess</surname> <given-names>C</given-names></name><name><surname>Höfer</surname> <given-names>T</given-names></name><name><surname>Hoffmann</surname> <given-names>P</given-names></name><name><surname>Hogquist</surname> <given-names>K</given-names></name><name><surname>Holland</surname> <given-names>T</given-names></name><name><surname>Höllt</surname> <given-names>T</given-names></name><name><surname>Holmdahl</surname> <given-names>R</given-names></name><name><surname>Hombrink</surname> <given-names>P</given-names></name><name><surname>Houston</surname> <given-names>JP</given-names></name><name><surname>Hoyer</surname> <given-names>BF</given-names></name><name><surname>Huang</surname> <given-names>B</given-names></name><name><surname>Huang</surname> <given-names>FP</given-names></name><name><surname>Huber</surname> <given-names>JE</given-names></name><name><surname>Huehn</surname> <given-names>J</given-names></name><name><surname>Hundemer</surname> <given-names>M</given-names></name><name><surname>Hunter</surname> <given-names>CA</given-names></name><name><surname>Hwang</surname> <given-names>WYK</given-names></name><name><surname>Iannone</surname> <given-names>A</given-names></name><name><surname>Ingelfinger</surname> <given-names>F</given-names></name><name><surname>Ivison</surname> <given-names>SM</given-names></name><name><surname>Jäck</surname> <given-names>HM</given-names></name><name><surname>Jani</surname> <given-names>PK</given-names></name><name><surname>Jávega</surname> <given-names>B</given-names></name><name><surname>Jonjic</surname> <given-names>S</given-names></name><name><surname>Kaiser</surname> <given-names>T</given-names></name><name><surname>Kalina</surname> <given-names>T</given-names></name><name><surname>Kamradt</surname> <given-names>T</given-names></name><name><surname>Kaufmann</surname> <given-names>SHE</given-names></name><name><surname>Keller</surname> <given-names>B</given-names></name><name><surname>Ketelaars</surname> <given-names>SLC</given-names></name><name><surname>Khalilnezhad</surname> <given-names>A</given-names></name><name><surname>Khan</surname> <given-names>S</given-names></name><name><surname>Kisielow</surname> <given-names>J</given-names></name><name><surname>Klenerman</surname> <given-names>P</given-names></name><name><surname>Knopf</surname> <given-names>J</given-names></name><name><surname>Koay</surname> <given-names>HF</given-names></name><name><surname>Kobow</surname> <given-names>K</given-names></name><name><surname>Kolls</surname> <given-names>JK</given-names></name><name><surname>Kong</surname> <given-names>WT</given-names></name><name><surname>Kopf</surname> <given-names>M</given-names></name><name><surname>Korn</surname> <given-names>T</given-names></name><name><surname>Kriegsmann</surname> <given-names>K</given-names></name><name><surname>Kristyanto</surname> <given-names>H</given-names></name><name><surname>Kroneis</surname> <given-names>T</given-names></name><name><surname>Krueger</surname> <given-names>A</given-names></name><name><surname>Kühne</surname> <given-names>J</given-names></name><name><surname>Kukat</surname> <given-names>C</given-names></name><name><surname>Kunkel</surname> <given-names>D</given-names></name><name><surname>Kunze-Schumacher</surname> <given-names>H</given-names></name><name><surname>Kurosaki</surname> <given-names>T</given-names></name><name><surname>Kurts</surname> <given-names>C</given-names></name><name><surname>Kvistborg</surname> <given-names>P</given-names></name><name><surname>Kwok</surname> <given-names>I</given-names></name><name><surname>Landry</surname> <given-names>J</given-names></name><name><surname>Lantz</surname> <given-names>O</given-names></name><name><surname>Lanuti</surname> <given-names>P</given-names></name><name><surname>LaRosa</surname> <given-names>F</given-names></name><name><surname>Lehuen</surname> <given-names>A</given-names></name><name><surname>LeibundGut-Landmann</surname> <given-names>S</given-names></name><name><surname>Leipold</surname> <given-names>MD</given-names></name><name><surname>Leung</surname> <given-names>LYT</given-names></name><name><surname>Levings</surname> <given-names>MK</given-names></name><name><surname>Lino</surname> <given-names>AC</given-names></name><name><surname>Liotta</surname> <given-names>F</given-names></name><name><surname>Litwin</surname> <given-names>V</given-names></name><name><surname>Liu</surname> <given-names>Y</given-names></name><name><surname>Ljunggren</surname> <given-names>HG</given-names></name><name><surname>Lohoff</surname> <given-names>M</given-names></name><name><surname>Lombardi</surname> <given-names>G</given-names></name><name><surname>Lopez</surname> <given-names>L</given-names></name><name><surname>López-Botet</surname> <given-names>M</given-names></name><name><surname>Lovett-Racke</surname> <given-names>AE</given-names></name><name><surname>Lubberts</surname> <given-names>E</given-names></name><name><surname>Luche</surname> <given-names>H</given-names></name><name><surname>Ludewig</surname> <given-names>B</given-names></name><name><surname>Lugli</surname> <given-names>E</given-names></name><name><surname>Lunemann</surname> <given-names>S</given-names></name><name><surname>Maecker</surname> <given-names>HT</given-names></name><name><surname>Maggi</surname> <given-names>L</given-names></name><name><surname>Maguire</surname> <given-names>O</given-names></name><name><surname>Mair</surname> <given-names>F</given-names></name><name><surname>Mair</surname> <given-names>KH</given-names></name><name><surname>Mantovani</surname> <given-names>A</given-names></name><name><surname>Manz</surname> <given-names>RA</given-names></name><name><surname>Marshall</surname> <given-names>AJ</given-names></name><name><surname>Martínez-Romero</surname> <given-names>A</given-names></name><name><surname>Martrus</surname> <given-names>G</given-names></name><name><surname>Marventano</surname> <given-names>I</given-names></name><name><surname>Maslinski</surname> <given-names>W</given-names></name><name><surname>Matarese</surname> <given-names>G</given-names></name><name><surname>Mattioli</surname> <given-names>AV</given-names></name><name><surname>Maueröder</surname> <given-names>C</given-names></name><name><surname>Mazzoni</surname> <given-names>A</given-names></name><name><surname>McCluskey</surname> <given-names>J</given-names></name><name><surname>McGrath</surname> <given-names>M</given-names></name><name><surname>McGuire</surname> <given-names>HM</given-names></name><name><surname>McInnes</surname> <given-names>IB</given-names></name><name><surname>Mei</surname> <given-names>HE</given-names></name><name><surname>Melchers</surname> <given-names>F</given-names></name><name><surname>Melzer</surname> <given-names>S</given-names></name><name><surname>Mielenz</surname> <given-names>D</given-names></name><name><surname>Miller</surname> <given-names>SD</given-names></name><name><surname>Mills</surname> <given-names>KHG</given-names></name><name><surname>Minderman</surname> <given-names>H</given-names></name><name><surname>Mjösberg</surname> <given-names>J</given-names></name><name><surname>Moore</surname> <given-names>J</given-names></name><name><surname>Moran</surname> <given-names>B</given-names></name><name><surname>Moretta</surname> <given-names>L</given-names></name><name><surname>Mosmann</surname> <given-names>TR</given-names></name><name><surname>Müller</surname> <given-names>S</given-names></name><name><surname>Multhoff</surname> <given-names>G</given-names></name><name><surname>Muñoz</surname> <given-names>LE</given-names></name><name><surname>Münz</surname> <given-names>C</given-names></name><name><surname>Nakayama</surname> <given-names>T</given-names></name><name><surname>Nasi</surname> <given-names>M</given-names></name><name><surname>Neumann</surname> <given-names>K</given-names></name><name><surname>Ng</surname> <given-names>LG</given-names></name><name><surname>Niedobitek</surname> <given-names>A</given-names></name><name><surname>Nourshargh</surname> <given-names>S</given-names></name><name><surname>Núñez</surname> <given-names>G</given-names></name><name><surname>O'Connor</surname> <given-names>JE</given-names></name><name><surname>Ochel</surname> <given-names>A</given-names></name><name><surname>Oja</surname> <given-names>A</given-names></name><name><surname>Ordonez</surname> <given-names>D</given-names></name><name><surname>Orfao</surname> <given-names>A</given-names></name><name><surname>Orlowski-Oliver</surname> <given-names>E</given-names></name><name><surname>Ouyang</surname> <given-names>W</given-names></name><name><surname>Oxenius</surname> <given-names>A</given-names></name><name><surname>Palankar</surname> <given-names>R</given-names></name><name><surname>Panse</surname> <given-names>I</given-names></name><name><surname>Pattanapanyasat</surname> <given-names>K</given-names></name><name><surname>Paulsen</surname> <given-names>M</given-names></name><name><surname>Pavlinic</surname> <given-names>D</given-names></name><name><surname>Penter</surname> <given-names>L</given-names></name><name><surname>Peterson</surname> <given-names>P</given-names></name><name><surname>Peth</surname> <given-names>C</given-names></name><name><surname>Petriz</surname> <given-names>J</given-names></name><name><surname>Piancone</surname> <given-names>F</given-names></name><name><surname>Pickl</surname> <given-names>WF</given-names></name><name><surname>Piconese</surname> <given-names>S</given-names></name><name><surname>Pinti</surname> <given-names>M</given-names></name><name><surname>Pockley</surname> <given-names>AG</given-names></name><name><surname>Podolska</surname> <given-names>MJ</given-names></name><name><surname>Poon</surname> <given-names>Z</given-names></name><name><surname>Pracht</surname> <given-names>K</given-names></name><name><surname>Prinz</surname> <given-names>I</given-names></name><name><surname>Pucillo</surname> <given-names>CEM</given-names></name><name><surname>Quataert</surname> <given-names>SA</given-names></name><name><surname>Quatrini</surname> <given-names>L</given-names></name><name><surname>Quinn</surname> <given-names>KM</given-names></name><name><surname>Radbruch</surname> <given-names>H</given-names></name><name><surname>Radstake</surname> <given-names>T</given-names></name><name><surname>Rahmig</surname> <given-names>S</given-names></name><name><surname>Rahn</surname> <given-names>HP</given-names></name><name><surname>Rajwa</surname> <given-names>B</given-names></name><name><surname>Ravichandran</surname> <given-names>G</given-names></name><name><surname>Raz</surname> <given-names>Y</given-names></name><name><surname>Rebhahn</surname> <given-names>JA</given-names></name><name><surname>Recktenwald</surname> <given-names>D</given-names></name><name><surname>Reimer</surname> <given-names>D</given-names></name><name><surname>Reis E Sousa</surname> <given-names>C</given-names></name><name><surname>Remmerswaal</surname> <given-names>EBM</given-names></name><name><surname>Richter</surname> <given-names>L</given-names></name><name><surname>Rico</surname> <given-names>LG</given-names></name><name><surname>Riddell</surname> <given-names>A</given-names></name><name><surname>Rieger</surname> <given-names>AM</given-names></name><name><surname>Robinson</surname> <given-names>JP</given-names></name><name><surname>Romagnani</surname> <given-names>C</given-names></name><name><surname>Rubartelli</surname> <given-names>A</given-names></name><name><surname>Ruland</surname> <given-names>J</given-names></name><name><surname>Saalmüller</surname> <given-names>A</given-names></name><name><surname>Saeys</surname> <given-names>Y</given-names></name><name><surname>Saito</surname> <given-names>T</given-names></name><name><surname>Sakaguchi</surname> <given-names>S</given-names></name><name><surname>Sala-de-Oyanguren</surname> <given-names>F</given-names></name><name><surname>Samstag</surname> <given-names>Y</given-names></name><name><surname>Sanderson</surname> <given-names>S</given-names></name><name><surname>Sandrock</surname> <given-names>I</given-names></name><name><surname>Santoni</surname> <given-names>A</given-names></name><name><surname>Sanz</surname> <given-names>RB</given-names></name><name><surname>Saresella</surname> <given-names>M</given-names></name><name><surname>Sautes-Fridman</surname> <given-names>C</given-names></name><name><surname>Sawitzki</surname> <given-names>B</given-names></name><name><surname>Schadt</surname> <given-names>L</given-names></name><name><surname>Scheffold</surname> <given-names>A</given-names></name><name><surname>Scherer</surname> <given-names>HU</given-names></name><name><surname>Schiemann</surname> <given-names>M</given-names></name><name><surname>Schildberg</surname> <given-names>FA</given-names></name><name><surname>Schimisky</surname> <given-names>E</given-names></name><name><surname>Schlitzer</surname> <given-names>A</given-names></name><name><surname>Schlosser</surname> <given-names>J</given-names></name><name><surname>Schmid</surname> <given-names>S</given-names></name><name><surname>Schmitt</surname> <given-names>S</given-names></name><name><surname>Schober</surname> <given-names>K</given-names></name><name><surname>Schraivogel</surname> <given-names>D</given-names></name><name><surname>Schuh</surname> <given-names>W</given-names></name><name><surname>Schüler</surname> <given-names>T</given-names></name><name><surname>Schulte</surname> <given-names>R</given-names></name><name><surname>Schulz</surname> <given-names>AR</given-names></name><name><surname>Schulz</surname> <given-names>SR</given-names></name><name><surname>Scottá</surname> <given-names>C</given-names></name><name><surname>Scott-Algara</surname> <given-names>D</given-names></name><name><surname>Sester</surname> <given-names>DP</given-names></name><name><surname>Shankey</surname> <given-names>TV</given-names></name><name><surname>Silva-Santos</surname> <given-names>B</given-names></name><name><surname>Simon</surname> <given-names>AK</given-names></name><name><surname>Sitnik</surname> <given-names>KM</given-names></name><name><surname>Sozzani</surname> <given-names>S</given-names></name><name><surname>Speiser</surname> <given-names>DE</given-names></name><name><surname>Spidlen</surname> <given-names>J</given-names></name><name><surname>Stahlberg</surname> <given-names>A</given-names></name><name><surname>Stall</surname> <given-names>AM</given-names></name><name><surname>Stanley</surname> <given-names>N</given-names></name><name><surname>Stark</surname> <given-names>R</given-names></name><name><surname>Stehle</surname> <given-names>C</given-names></name><name><surname>Steinmetz</surname> <given-names>T</given-names></name><name><surname>Stockinger</surname> <given-names>H</given-names></name><name><surname>Takahama</surname> <given-names>Y</given-names></name><name><surname>Takeda</surname> <given-names>K</given-names></name><name><surname>Tan</surname> <given-names>L</given-names></name><name><surname>Tárnok</surname> <given-names>A</given-names></name><name><surname>Tiegs</surname> <given-names>G</given-names></name><name><surname>Toldi</surname> <given-names>G</given-names></name><name><surname>Tornack</surname> <given-names>J</given-names></name><name><surname>Traggiai</surname> <given-names>E</given-names></name><name><surname>Trebak</surname> <given-names>M</given-names></name><name><surname>Tree</surname> <given-names>TIM</given-names></name><name><surname>Trotter</surname> <given-names>J</given-names></name><name><surname>Trowsdale</surname> <given-names>J</given-names></name><name><surname>Tsoumakidou</surname> <given-names>M</given-names></name><name><surname>Ulrich</surname> <given-names>H</given-names></name><name><surname>Urbanczyk</surname> <given-names>S</given-names></name><name><surname>van de Veen</surname> <given-names>W</given-names></name><name><surname>van den Broek</surname> <given-names>M</given-names></name><name><surname>van der Pol</surname> <given-names>E</given-names></name><name><surname>Van Gassen</surname> <given-names>S</given-names></name><name><surname>Van Isterdael</surname> <given-names>G</given-names></name><name><surname>van Lier</surname> <given-names>RAW</given-names></name><name><surname>Veldhoen</surname> <given-names>M</given-names></name><name><surname>Vento-Asturias</surname> <given-names>S</given-names></name><name><surname>Vieira</surname> <given-names>P</given-names></name><name><surname>Voehringer</surname> <given-names>D</given-names></name><name><surname>Volk</surname> <given-names>HD</given-names></name><name><surname>von Borstel</surname> <given-names>A</given-names></name><name><surname>von Volkmann</surname> <given-names>K</given-names></name><name><surname>Waisman</surname> <given-names>A</given-names></name><name><surname>Walker</surname> <given-names>RV</given-names></name><name><surname>Wallace</surname> <given-names>PK</given-names></name><name><surname>Wang</surname> <given-names>SA</given-names></name><name><surname>Wang</surname> <given-names>XM</given-names></name><name><surname>Ward</surname> <given-names>MD</given-names></name><name><surname>Ward-Hartstonge</surname> <given-names>KA</given-names></name><name><surname>Warnatz</surname> <given-names>K</given-names></name><name><surname>Warnes</surname> <given-names>G</given-names></name><name><surname>Warth</surname> <given-names>S</given-names></name><name><surname>Waskow</surname> <given-names>C</given-names></name><name><surname>Watson</surname> <given-names>JV</given-names></name><name><surname>Watzl</surname> <given-names>C</given-names></name><name><surname>Wegener</surname> <given-names>L</given-names></name><name><surname>Weisenburger</surname> <given-names>T</given-names></name><name><surname>Wiedemann</surname> <given-names>A</given-names></name><name><surname>Wienands</surname> <given-names>J</given-names></name><name><surname>Wilharm</surname> <given-names>A</given-names></name><name><surname>Wilkinson</surname> <given-names>RJ</given-names></name><name><surname>Willimsky</surname> <given-names>G</given-names></name><name><surname>Wing</surname> <given-names>JB</given-names></name><name><surname>Winkelmann</surname> <given-names>R</given-names></name><name><surname>Winkler</surname> <given-names>TH</given-names></name><name><surname>Wirz</surname> <given-names>OF</given-names></name><name><surname>Wong</surname> <given-names>A</given-names></name><name><surname>Wurst</surname> <given-names>P</given-names></name><name><surname>Yang</surname> <given-names>JHM</given-names></name><name><surname>Yang</surname> <given-names>J</given-names></name><name><surname>Yazdanbakhsh</surname> <given-names>M</given-names></name><name><surname>Yu</surname> <given-names>L</given-names></name><name><surname>Yue</surname> <given-names>A</given-names></name><name><surname>Zhang</surname> <given-names>H</given-names></name><name><surname>Zhao</surname> <given-names>Y</given-names></name><name><surname>Ziegler</surname> <given-names>SM</given-names></name><name><surname>Zielinski</surname> <given-names>C</given-names></name><name><surname>Zimmermann</surname> <given-names>J</given-names></name><name><surname>Zychlinsky</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)</article-title><source>European Journal of Immunology</source><volume>49</volume><fpage>1457</fpage><lpage>1973</lpage><pub-id pub-id-type="doi">10.1002/eji.201970107</pub-id><pub-id pub-id-type="pmid">31633216</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eberl</surname> <given-names>G</given-names></name><name><surname>Marmon</surname> <given-names>S</given-names></name><name><surname>Sunshine</surname> <given-names>MJ</given-names></name><name><surname>Rennert</surname> <given-names>PD</given-names></name><name><surname>Choi</surname> <given-names>Y</given-names></name><name><surname>Littman</surname> <given-names>DR</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>An essential function for the nuclear receptor RORgamma(t) in the generation of fetal lymphoid tissue inducer cells</article-title><source>Nature Immunology</source><volume>5</volume><fpage>64</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1038/ni1022</pub-id><pub-id pub-id-type="pmid">14691482</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eberl</surname> <given-names>G</given-names></name><name><surname>Littman</surname> <given-names>DR</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Thymic origin of intestinal alphabeta T cells revealed by fate mapping of RORgammat+ cells</article-title><source>Science</source><volume>305</volume><fpage>248</fpage><lpage>251</lpage><pub-id pub-id-type="doi">10.1126/science.1096472</pub-id><pub-id pub-id-type="pmid">15247480</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname> <given-names>D</given-names></name><name><surname>Zhu</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Dynamic balance between master transcription factors determines the fates and functions of CD4 T cell and innate lymphoid cell subsets</article-title><source>The Journal of Experimental Medicine</source><volume>214</volume><fpage>1861</fpage><lpage>1876</lpage><pub-id pub-id-type="doi">10.1084/jem.20170494</pub-id><pub-id pub-id-type="pmid">28630089</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gladiator</surname> <given-names>A</given-names></name><name><surname>Wangler</surname> <given-names>N</given-names></name><name><surname>Trautwein-Weidner</surname> <given-names>K</given-names></name><name><surname>LeibundGut-Landmann</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Cutting edge: il-17-secreting innate lymphoid cells are essential for host defense against fungal infection</article-title><source>The Journal of Immunology</source><volume>190</volume><fpage>521</fpage><lpage>525</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1202924</pub-id><pub-id pub-id-type="pmid">23255360</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gökmen</surname> <given-names>MR</given-names></name><name><surname>Dong</surname> <given-names>R</given-names></name><name><surname>Kanhere</surname> <given-names>A</given-names></name><name><surname>Powell</surname> <given-names>N</given-names></name><name><surname>Perucha</surname> <given-names>E</given-names></name><name><surname>Jackson</surname> <given-names>I</given-names></name><name><surname>Howard</surname> <given-names>JK</given-names></name><name><surname>Hernandez-Fuentes</surname> <given-names>M</given-names></name><name><surname>Jenner</surname> <given-names>RG</given-names></name><name><surname>Lord</surname> <given-names>GM</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Genome-wide regulatory analysis reveals that T-bet controls Th17 lineage differentiation through direct suppression of IRF4</article-title><source>The Journal of Immunology</source><volume>191</volume><fpage>5925</fpage><lpage>5932</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1202254</pub-id><pub-id pub-id-type="pmid">24249732</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gronke</surname> <given-names>K</given-names></name><name><surname>Hernández</surname> <given-names>PP</given-names></name><name><surname>Zimmermann</surname> <given-names>J</given-names></name><name><surname>Klose</surname> <given-names>CSN</given-names></name><name><surname>Kofoed-Branzk</surname> <given-names>M</given-names></name><name><surname>Guendel</surname> <given-names>F</given-names></name><name><surname>Witkowski</surname> <given-names>M</given-names></name><name><surname>Tizian</surname> <given-names>C</given-names></name><name><surname>Amann</surname> <given-names>L</given-names></name><name><surname>Schumacher</surname> <given-names>F</given-names></name><name><surname>Glatt</surname> <given-names>H</given-names></name><name><surname>Triantafyllopoulou</surname> <given-names>A</given-names></name><name><surname>Diefenbach</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Interleukin-22 protects intestinal stem cells against genotoxic stress</article-title><source>Nature</source><volume>566</volume><fpage>249</fpage><lpage>253</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-0899-7</pub-id><pub-id pub-id-type="pmid">30700914</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heinz</surname> <given-names>S</given-names></name><name><surname>Benner</surname> <given-names>C</given-names></name><name><surname>Spann</surname> <given-names>N</given-names></name><name><surname>Bertolino</surname> <given-names>E</given-names></name><name><surname>Lin</surname> <given-names>YC</given-names></name><name><surname>Laslo</surname> <given-names>P</given-names></name><name><surname>Cheng</surname> <given-names>JX</given-names></name><name><surname>Murre</surname> <given-names>C</given-names></name><name><surname>Singh</surname> <given-names>H</given-names></name><name><surname>Glass</surname> <given-names>CK</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities</article-title><source>Molecular Cell</source><volume>38</volume><fpage>576</fpage><lpage>589</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2010.05.004</pub-id><pub-id pub-id-type="pmid">20513432</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hernández</surname> <given-names>PP</given-names></name><name><surname>Mahlakoiv</surname> <given-names>T</given-names></name><name><surname>Yang</surname> <given-names>I</given-names></name><name><surname>Schwierzeck</surname> <given-names>V</given-names></name><name><surname>Nguyen</surname> <given-names>N</given-names></name><name><surname>Guendel</surname> <given-names>F</given-names></name><name><surname>Gronke</surname> <given-names>K</given-names></name><name><surname>Ryffel</surname> <given-names>B</given-names></name><name><surname>Hoelscher</surname> <given-names>C</given-names></name><name><surname>Dumoutier</surname> <given-names>L</given-names></name><name><surname>Renauld</surname> <given-names>JC</given-names></name><name><surname>Suerbaum</surname> <given-names>S</given-names></name><name><surname>Staeheli</surname> <given-names>P</given-names></name><name><surname>Diefenbach</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Interferon-λ and interleukin 22 act synergistically for the induction of interferon-stimulated genes and control of Rotavirus infection</article-title><source>Nature Immunology</source><volume>16</volume><fpage>698</fpage><lpage>707</lpage><pub-id pub-id-type="doi">10.1038/ni.3180</pub-id><pub-id pub-id-type="pmid">26006013</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ho</surname> <given-names>IC</given-names></name><name><surname>Lo</surname> <given-names>D</given-names></name><name><surname>Glimcher</surname> <given-names>LH</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>c-maf promotes T helper cell type 2 (Th2) and attenuates Th1 differentiation by both interleukin 4–dependent and –independent Mechanisms</article-title><source>The Journal of Experimental Medicine</source><volume>188</volume><fpage>1859</fpage><lpage>1866</lpage><pub-id pub-id-type="doi">10.1084/jem.188.10.1859</pub-id><pub-id pub-id-type="pmid">9815263</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hosokawa</surname> <given-names>H</given-names></name><name><surname>Tanaka</surname> <given-names>T</given-names></name><name><surname>Suzuki</surname> <given-names>Y</given-names></name><name><surname>Iwamura</surname> <given-names>C</given-names></name><name><surname>Ohkubo</surname> <given-names>S</given-names></name><name><surname>Endoh</surname> <given-names>K</given-names></name><name><surname>Kato</surname> <given-names>M</given-names></name><name><surname>Endo</surname> <given-names>Y</given-names></name><name><surname>Onodera</surname> <given-names>A</given-names></name><name><surname>Tumes</surname> <given-names>DJ</given-names></name><name><surname>Kanai</surname> <given-names>A</given-names></name><name><surname>Sugano</surname> <given-names>S</given-names></name><name><surname>Nakayama</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Functionally distinct Gata3/Chd4 complexes coordinately establish T helper 2 (Th2) cell identity</article-title><source>PNAS</source><volume>110</volume><fpage>4691</fpage><lpage>4696</lpage><pub-id pub-id-type="doi">10.1073/pnas.1220865110</pub-id><pub-id pub-id-type="pmid">23471993</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imbratta</surname> <given-names>C</given-names></name><name><surname>Leblond</surname> <given-names>MM</given-names></name><name><surname>Bouzourène</surname> <given-names>H</given-names></name><name><surname>Speiser</surname> <given-names>DE</given-names></name><name><surname>Velin</surname> <given-names>D</given-names></name><name><surname>Verdeil</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Maf deficiency in T cells dysregulates T<sub>reg</sub> - T<sub>H</sub>17 balance leading to spontaneous colitis</article-title><source>Scientific Reports</source><volume>9</volume><elocation-id>6135</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-019-42486-2</pub-id><pub-id pub-id-type="pmid">30992496</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ivanov</surname> <given-names>II</given-names></name><name><surname>McKenzie</surname> <given-names>BS</given-names></name><name><surname>Zhou</surname> <given-names>L</given-names></name><name><surname>Tadokoro</surname> <given-names>CE</given-names></name><name><surname>Lepelley</surname> <given-names>A</given-names></name><name><surname>Lafaille</surname> <given-names>JJ</given-names></name><name><surname>Cua</surname> <given-names>DJ</given-names></name><name><surname>Littman</surname> <given-names>DR</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells</article-title><source>Cell</source><volume>126</volume><fpage>1121</fpage><lpage>1133</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2006.07.035</pub-id><pub-id pub-id-type="pmid">16990136</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kataoka</surname> <given-names>K</given-names></name><name><surname>Noda</surname> <given-names>M</given-names></name><name><surname>Nishizawa</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Maf nuclear oncoprotein recognizes sequences related to an AP-1 site and forms heterodimers with both fos and jun</article-title><source>Molecular and Cellular Biology</source><volume>14</volume><fpage>700</fpage><lpage>712</lpage><pub-id pub-id-type="doi">10.1128/MCB.14.1.700</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>D</given-names></name><name><surname>Pertea</surname> <given-names>G</given-names></name><name><surname>Trapnell</surname> <given-names>C</given-names></name><name><surname>Pimentel</surname> <given-names>H</given-names></name><name><surname>Kelley</surname> <given-names>R</given-names></name><name><surname>Salzberg</surname> <given-names>SL</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions</article-title><source>Genome Biology</source><volume>14</volume><elocation-id>R36</elocation-id><pub-id pub-id-type="doi">10.1186/gb-2013-14-4-r36</pub-id><pub-id pub-id-type="pmid">23618408</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klose</surname> <given-names>CS</given-names></name><name><surname>Kiss</surname> <given-names>EA</given-names></name><name><surname>Schwierzeck</surname> <given-names>V</given-names></name><name><surname>Ebert</surname> <given-names>K</given-names></name><name><surname>Hoyler</surname> <given-names>T</given-names></name><name><surname>d'Hargues</surname> <given-names>Y</given-names></name><name><surname>Göppert</surname> <given-names>N</given-names></name><name><surname>Croxford</surname> <given-names>AL</given-names></name><name><surname>Waisman</surname> <given-names>A</given-names></name><name><surname>Tanriver</surname> <given-names>Y</given-names></name><name><surname>Diefenbach</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>A T-bet gradient controls the fate and function of CCR6-RORγt+ innate lymphoid cells</article-title><source>Nature</source><volume>494</volume><fpage>261</fpage><lpage>265</lpage><pub-id pub-id-type="doi">10.1038/nature11813</pub-id><pub-id pub-id-type="pmid">23334414</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klose</surname> <given-names>CSN</given-names></name><name><surname>Flach</surname> <given-names>M</given-names></name><name><surname>Möhle</surname> <given-names>L</given-names></name><name><surname>Rogell</surname> <given-names>L</given-names></name><name><surname>Hoyler</surname> <given-names>T</given-names></name><name><surname>Ebert</surname> <given-names>K</given-names></name><name><surname>Fabiunke</surname> <given-names>C</given-names></name><name><surname>Pfeifer</surname> <given-names>D</given-names></name><name><surname>Sexl</surname> <given-names>V</given-names></name><name><surname>Fonseca-Pereira</surname> <given-names>D</given-names></name><name><surname>Domingues</surname> <given-names>RG</given-names></name><name><surname>Veiga-Fernandes</surname> <given-names>H</given-names></name><name><surname>Arnold</surname> <given-names>SJ</given-names></name><name><surname>Busslinger</surname> <given-names>M</given-names></name><name><surname>Dunay</surname> <given-names>IR</given-names></name><name><surname>Tanriver</surname> <given-names>Y</given-names></name><name><surname>Diefenbach</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages</article-title><source>Cell</source><volume>157</volume><fpage>340</fpage><lpage>356</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.03.030</pub-id><pub-id pub-id-type="pmid">24725403</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langmead</surname> <given-names>B</given-names></name><name><surname>Salzberg</surname> <given-names>SL</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Fast gapped-read alignment with bowtie 2</article-title><source>Nature Methods</source><volume>9</volume><fpage>357</fpage><lpage>359</lpage><pub-id pub-id-type="doi">10.1038/nmeth.1923</pub-id><pub-id pub-id-type="pmid">22388286</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>PP</given-names></name><name><surname>Fitzpatrick</surname> <given-names>DR</given-names></name><name><surname>Beard</surname> <given-names>C</given-names></name><name><surname>Jessup</surname> <given-names>HK</given-names></name><name><surname>Lehar</surname> <given-names>S</given-names></name><name><surname>Makar</surname> <given-names>KW</given-names></name><name><surname>Pérez-Melgosa</surname> <given-names>M</given-names></name><name><surname>Sweetser</surname> <given-names>MT</given-names></name><name><surname>Schlissel</surname> <given-names>MS</given-names></name><name><surname>Nguyen</surname> <given-names>S</given-names></name><name><surname>Cherry</surname> <given-names>SR</given-names></name><name><surname>Tsai</surname> <given-names>JH</given-names></name><name><surname>Tucker</surname> <given-names>SM</given-names></name><name><surname>Weaver</surname> <given-names>WM</given-names></name><name><surname>Kelso</surname> <given-names>A</given-names></name><name><surname>Jaenisch</surname> <given-names>R</given-names></name><name><surname>Wilson</surname> <given-names>CB</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival</article-title><source>Immunity</source><volume>15</volume><fpage>763</fpage><lpage>774</lpage><pub-id pub-id-type="doi">10.1016/S1074-7613(01)00227-8</pub-id><pub-id pub-id-type="pmid">11728338</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname> <given-names>Y</given-names></name><name><surname>Smyth</surname> <given-names>GK</given-names></name><name><surname>Shi</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>featureCounts: an efficient general purpose program for assigning sequence reads to genomic features</article-title><source>Bioinformatics</source><volume>30</volume><fpage>923</fpage><lpage>930</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btt656</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Love</surname> <given-names>MI</given-names></name><name><surname>Huber</surname> <given-names>W</given-names></name><name><surname>Anders</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title><source>Genome Biology</source><volume>15</volume><elocation-id>550</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mei</surname> <given-names>S</given-names></name><name><surname>Qin</surname> <given-names>Q</given-names></name><name><surname>Wu</surname> <given-names>Q</given-names></name><name><surname>Sun</surname> <given-names>H</given-names></name><name><surname>Zheng</surname> <given-names>R</given-names></name><name><surname>Zang</surname> <given-names>C</given-names></name><name><surname>Zhu</surname> <given-names>M</given-names></name><name><surname>Wu</surname> <given-names>J</given-names></name><name><surname>Shi</surname> <given-names>X</given-names></name><name><surname>Taing</surname> <given-names>L</given-names></name><name><surname>Liu</surname> <given-names>T</given-names></name><name><surname>Brown</surname> <given-names>M</given-names></name><name><surname>Meyer</surname> <given-names>CA</given-names></name><name><surname>Liu</surname> <given-names>XS</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Cistrome data browser: a data portal for ChIP-Seq and chromatin accessibility data in human and mouse</article-title><source>Nucleic Acids Research</source><volume>45</volume><fpage>D658</fpage><lpage>D662</lpage><pub-id pub-id-type="doi">10.1093/nar/gkw983</pub-id><pub-id pub-id-type="pmid">27789702</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melo-Gonzalez</surname> <given-names>F</given-names></name><name><surname>Hepworth</surname> <given-names>MR</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Functional and phenotypic heterogeneity of group 3 innate lymphoid cells</article-title><source>Immunology</source><volume>150</volume><fpage>265</fpage><lpage>275</lpage><pub-id pub-id-type="doi">10.1111/imm.12697</pub-id><pub-id pub-id-type="pmid">27935637</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neumann</surname> <given-names>C</given-names></name><name><surname>Heinrich</surname> <given-names>F</given-names></name><name><surname>Neumann</surname> <given-names>K</given-names></name><name><surname>Junghans</surname> <given-names>V</given-names></name><name><surname>Mashreghi</surname> <given-names>MF</given-names></name><name><surname>Ahlers</surname> <given-names>J</given-names></name><name><surname>Janke</surname> <given-names>M</given-names></name><name><surname>Rudolph</surname> <given-names>C</given-names></name><name><surname>Mockel-Tenbrinck</surname> <given-names>N</given-names></name><name><surname>Kühl</surname> <given-names>AA</given-names></name><name><surname>Heimesaat</surname> <given-names>MM</given-names></name><name><surname>Esser</surname> <given-names>C</given-names></name><name><surname>Im</surname> <given-names>SH</given-names></name><name><surname>Radbruch</surname> <given-names>A</given-names></name><name><surname>Rutz</surname> <given-names>S</given-names></name><name><surname>Scheffold</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Role of Blimp-1 in programing th effector cells into IL-10 producers</article-title><source>The Journal of Experimental Medicine</source><volume>211</volume><fpage>1807</fpage><lpage>1819</lpage><pub-id pub-id-type="doi">10.1084/jem.20131548</pub-id><pub-id pub-id-type="pmid">25073792</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neumann</surname> <given-names>C</given-names></name><name><surname>Blume</surname> <given-names>J</given-names></name><name><surname>Roy</surname> <given-names>U</given-names></name><name><surname>Teh</surname> <given-names>PP</given-names></name><name><surname>Vasanthakumar</surname> <given-names>A</given-names></name><name><surname>Beller</surname> <given-names>A</given-names></name><name><surname>Liao</surname> <given-names>Y</given-names></name><name><surname>Heinrich</surname> <given-names>F</given-names></name><name><surname>Arenzana</surname> <given-names>TL</given-names></name><name><surname>Hackney</surname> <given-names>JA</given-names></name><name><surname>Eidenschenk</surname> <given-names>C</given-names></name><name><surname>Gálvez</surname> <given-names>EJC</given-names></name><name><surname>Stehle</surname> <given-names>C</given-names></name><name><surname>Heinz</surname> <given-names>GA</given-names></name><name><surname>Maschmeyer</surname> <given-names>P</given-names></name><name><surname>Sidwell</surname> <given-names>T</given-names></name><name><surname>Hu</surname> <given-names>Y</given-names></name><name><surname>Amsen</surname> <given-names>D</given-names></name><name><surname>Romagnani</surname> <given-names>C</given-names></name><name><surname>Chang</surname> <given-names>HD</given-names></name><name><surname>Kruglov</surname> <given-names>A</given-names></name><name><surname>Mashreghi</surname> <given-names>MF</given-names></name><name><surname>Shi</surname> <given-names>W</given-names></name><name><surname>Strowig</surname> <given-names>T</given-names></name><name><surname>Rutz</surname> <given-names>S</given-names></name><name><surname>Kallies</surname> <given-names>A</given-names></name><name><surname>Scheffold</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>c-Maf-dependent T<sub>reg</sub> cell control of intestinal T<sub>H</sub>17 cells and IgA establishes host-microbiota homeostasis</article-title><source>Nature Immunology</source><volume>20</volume><fpage>471</fpage><lpage>481</lpage><pub-id pub-id-type="doi">10.1038/s41590-019-0316-2</pub-id><pub-id pub-id-type="pmid">30778241</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parker</surname> <given-names>ME</given-names></name><name><surname>Barrera</surname> <given-names>A</given-names></name><name><surname>Wheaton</surname> <given-names>JD</given-names></name><name><surname>Zuberbuehler</surname> <given-names>MK</given-names></name><name><surname>Allan</surname> <given-names>DSJ</given-names></name><name><surname>Carlyle</surname> <given-names>JR</given-names></name><name><surname>Reddy</surname> <given-names>TE</given-names></name><name><surname>Ciofani</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>c-Maf regulates the plasticity of group 3 innate lymphoid cells by restraining the type 1 program</article-title><source>The Journal of Experimental Medicine</source><volume>217</volume><pub-id pub-id-type="doi">10.1084/jem.20191030</pub-id><pub-id pub-id-type="pmid">31570496</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pokrovskii</surname> <given-names>M</given-names></name><name><surname>Hall</surname> <given-names>JA</given-names></name><name><surname>Ochayon</surname> <given-names>DE</given-names></name><name><surname>Yi</surname> <given-names>R</given-names></name><name><surname>Chaimowitz</surname> <given-names>NS</given-names></name><name><surname>Seelamneni</surname> <given-names>H</given-names></name><name><surname>Carriero</surname> <given-names>N</given-names></name><name><surname>Watters</surname> <given-names>A</given-names></name><name><surname>Waggoner</surname> <given-names>SN</given-names></name><name><surname>Littman</surname> <given-names>DR</given-names></name><name><surname>Bonneau</surname> <given-names>R</given-names></name><name><surname>Miraldi</surname> <given-names>ER</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Characterization of transcriptional regulatory networks that promote and restrict identities and functions of intestinal innate lymphoid cells</article-title><source>Immunity</source><volume>51</volume><fpage>185</fpage><lpage>197</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2019.06.001</pub-id><pub-id pub-id-type="pmid">31278058</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Powell</surname> <given-names>N</given-names></name><name><surname>Walker</surname> <given-names>AW</given-names></name><name><surname>Stolarczyk</surname> <given-names>E</given-names></name><name><surname>Canavan</surname> <given-names>JB</given-names></name><name><surname>Gökmen</surname> <given-names>MR</given-names></name><name><surname>Marks</surname> <given-names>E</given-names></name><name><surname>Jackson</surname> <given-names>I</given-names></name><name><surname>Hashim</surname> <given-names>A</given-names></name><name><surname>Curtis</surname> <given-names>MA</given-names></name><name><surname>Jenner</surname> <given-names>RG</given-names></name><name><surname>Howard</surname> <given-names>JK</given-names></name><name><surname>Parkhill</surname> <given-names>J</given-names></name><name><surname>MacDonald</surname> <given-names>TT</given-names></name><name><surname>Lord</surname> <given-names>GM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The transcription factor T-bet regulates intestinal inflammation mediated by interleukin-7 receptor+ innate lymphoid cells</article-title><source>Immunity</source><volume>37</volume><fpage>674</fpage><lpage>684</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2012.09.008</pub-id><pub-id pub-id-type="pmid">23063332</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rankin</surname> <given-names>LC</given-names></name><name><surname>Groom</surname> <given-names>JR</given-names></name><name><surname>Chopin</surname> <given-names>M</given-names></name><name><surname>Herold</surname> <given-names>MJ</given-names></name><name><surname>Walker</surname> <given-names>JA</given-names></name><name><surname>Mielke</surname> <given-names>LA</given-names></name><name><surname>McKenzie</surname> <given-names>AN</given-names></name><name><surname>Carotta</surname> <given-names>S</given-names></name><name><surname>Nutt</surname> <given-names>SL</given-names></name><name><surname>Belz</surname> <given-names>GT</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The transcription factor T-bet is essential for the development of NKp46+ innate lymphocytes via the notch pathway</article-title><source>Nature Immunology</source><volume>14</volume><fpage>389</fpage><lpage>395</lpage><pub-id pub-id-type="doi">10.1038/ni.2545</pub-id><pub-id pub-id-type="pmid">23455676</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rankin</surname> <given-names>LC</given-names></name><name><surname>Girard-Madoux</surname> <given-names>MJ</given-names></name><name><surname>Seillet</surname> <given-names>C</given-names></name><name><surname>Mielke</surname> <given-names>LA</given-names></name><name><surname>Kerdiles</surname> <given-names>Y</given-names></name><name><surname>Fenis</surname> <given-names>A</given-names></name><name><surname>Wieduwild</surname> <given-names>E</given-names></name><name><surname>Putoczki</surname> <given-names>T</given-names></name><name><surname>Mondot</surname> <given-names>S</given-names></name><name><surname>Lantz</surname> <given-names>O</given-names></name><name><surname>Demon</surname> <given-names>D</given-names></name><name><surname>Papenfuss</surname> <given-names>AT</given-names></name><name><surname>Smyth</surname> <given-names>GK</given-names></name><name><surname>Lamkanfi</surname> <given-names>M</given-names></name><name><surname>Carotta</surname> <given-names>S</given-names></name><name><surname>Renauld</surname> <given-names>JC</given-names></name><name><surname>Shi</surname> <given-names>W</given-names></name><name><surname>Carpentier</surname> <given-names>S</given-names></name><name><surname>Soos</surname> <given-names>T</given-names></name><name><surname>Arendt</surname> <given-names>C</given-names></name><name><surname>Ugolini</surname> <given-names>S</given-names></name><name><surname>Huntington</surname> <given-names>ND</given-names></name><name><surname>Belz</surname> <given-names>GT</given-names></name><name><surname>Vivier</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Complementarity and redundancy of IL-22-producing innate lymphoid cells</article-title><source>Nature Immunology</source><volume>17</volume><fpage>179</fpage><lpage>186</lpage><pub-id pub-id-type="doi">10.1038/ni.3332</pub-id><pub-id pub-id-type="pmid">26595889</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinette</surname> <given-names>ML</given-names></name><name><surname>Fuchs</surname> <given-names>A</given-names></name><name><surname>Cortez</surname> <given-names>VS</given-names></name><name><surname>Lee</surname> <given-names>JS</given-names></name><name><surname>Wang</surname> <given-names>Y</given-names></name><name><surname>Durum</surname> <given-names>SK</given-names></name><name><surname>Gilfillan</surname> <given-names>S</given-names></name><name><surname>Colonna</surname> <given-names>M</given-names></name><collab>Immunological Genome Consortium</collab></person-group><year iso-8601-date="2015">2015</year><article-title>Transcriptional programs define molecular characteristics of innate lymphoid cell classes and subsets</article-title><source>Nature Immunology</source><volume>16</volume><fpage>306</fpage><lpage>317</lpage><pub-id pub-id-type="doi">10.1038/ni.3094</pub-id><pub-id pub-id-type="pmid">25621825</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rutz</surname> <given-names>S</given-names></name><name><surname>Noubade</surname> <given-names>R</given-names></name><name><surname>Eidenschenk</surname> <given-names>C</given-names></name><name><surname>Ota</surname> <given-names>N</given-names></name><name><surname>Zeng</surname> <given-names>W</given-names></name><name><surname>Zheng</surname> <given-names>Y</given-names></name><name><surname>Hackney</surname> <given-names>J</given-names></name><name><surname>Ding</surname> <given-names>J</given-names></name><name><surname>Singh</surname> <given-names>H</given-names></name><name><surname>Ouyang</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Transcription factor c-Maf mediates the TGF-β-dependent suppression of IL-22 production in T(H)17 cells</article-title><source>Nature Immunology</source><volume>12</volume><fpage>1238</fpage><lpage>1245</lpage><pub-id pub-id-type="doi">10.1038/ni.2134</pub-id><pub-id pub-id-type="pmid">22001828</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rutz</surname> <given-names>S</given-names></name><name><surname>Eidenschenk</surname> <given-names>C</given-names></name><name><surname>Ouyang</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>IL-22, not simply a Th17 cytokine</article-title><source>Immunological Reviews</source><volume>252</volume><fpage>116</fpage><lpage>132</lpage><pub-id pub-id-type="doi">10.1111/imr.12027</pub-id><pub-id pub-id-type="pmid">23405899</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanos</surname> <given-names>SL</given-names></name><name><surname>Bui</surname> <given-names>VL</given-names></name><name><surname>Mortha</surname> <given-names>A</given-names></name><name><surname>Oberle</surname> <given-names>K</given-names></name><name><surname>Heners</surname> <given-names>C</given-names></name><name><surname>Johner</surname> <given-names>C</given-names></name><name><surname>Diefenbach</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>RORγt and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+ cells</article-title><source>Nature Immunology</source><volume>10</volume><fpage>83</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1038/ni.1684</pub-id><pub-id pub-id-type="pmid">19029903</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Satoh-Takayama</surname> <given-names>N</given-names></name><name><surname>Vosshenrich</surname> <given-names>CA</given-names></name><name><surname>Lesjean-Pottier</surname> <given-names>S</given-names></name><name><surname>Sawa</surname> <given-names>S</given-names></name><name><surname>Lochner</surname> <given-names>M</given-names></name><name><surname>Rattis</surname> <given-names>F</given-names></name><name><surname>Mention</surname> <given-names>JJ</given-names></name><name><surname>Thiam</surname> <given-names>K</given-names></name><name><surname>Cerf-Bensussan</surname> <given-names>N</given-names></name><name><surname>Mandelboim</surname> <given-names>O</given-names></name><name><surname>Eberl</surname> <given-names>G</given-names></name><name><surname>Di Santo</surname> <given-names>JP</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense</article-title><source>Immunity</source><volume>29</volume><fpage>958</fpage><lpage>970</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2008.11.001</pub-id><pub-id pub-id-type="pmid">19084435</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Satoh-Takayama</surname> <given-names>N</given-names></name><name><surname>Lesjean-Pottier</surname> <given-names>S</given-names></name><name><surname>Vieira</surname> <given-names>P</given-names></name><name><surname>Sawa</surname> <given-names>S</given-names></name><name><surname>Eberl</surname> <given-names>G</given-names></name><name><surname>Vosshenrich</surname> <given-names>CA</given-names></name><name><surname>Di Santo</surname> <given-names>JP</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>IL-7 and IL-15 independently program the differentiation of intestinal CD3-NKp46+ cell subsets from Id2-dependent precursors</article-title><source>The Journal of Experimental Medicine</source><volume>207</volume><fpage>273</fpage><lpage>280</lpage><pub-id pub-id-type="doi">10.1084/jem.20092029</pub-id><pub-id pub-id-type="pmid">20142427</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sawa</surname> <given-names>S</given-names></name><name><surname>Cherrier</surname> <given-names>M</given-names></name><name><surname>Lochner</surname> <given-names>M</given-names></name><name><surname>Satoh-Takayama</surname> <given-names>N</given-names></name><name><surname>Fehling</surname> <given-names>HJ</given-names></name><name><surname>Langa</surname> <given-names>F</given-names></name><name><surname>Di Santo</surname> <given-names>JP</given-names></name><name><surname>Eberl</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Lineage relationship analysis of RORgammat+ innate lymphoid cells</article-title><source>Science</source><volume>330</volume><fpage>665</fpage><lpage>669</lpage><pub-id pub-id-type="doi">10.1126/science.1194597</pub-id><pub-id pub-id-type="pmid">20929731</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmitt</surname> <given-names>TM</given-names></name><name><surname>Zúñiga-Pflücker</surname> <given-names>JC</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Induction of T cell development from hematopoietic progenitor cells by delta-like-1 in vitro</article-title><source>Immunity</source><volume>17</volume><fpage>749</fpage><lpage>756</lpage><pub-id pub-id-type="doi">10.1016/S1074-7613(02)00474-0</pub-id><pub-id pub-id-type="pmid">12479821</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sciumé</surname> <given-names>G</given-names></name><name><surname>Hirahara</surname> <given-names>K</given-names></name><name><surname>Takahashi</surname> <given-names>H</given-names></name><name><surname>Laurence</surname> <given-names>A</given-names></name><name><surname>Villarino</surname> <given-names>AV</given-names></name><name><surname>Singleton</surname> <given-names>KL</given-names></name><name><surname>Spencer</surname> <given-names>SP</given-names></name><name><surname>Wilhelm</surname> <given-names>C</given-names></name><name><surname>Poholek</surname> <given-names>AC</given-names></name><name><surname>Vahedi</surname> <given-names>G</given-names></name><name><surname>Kanno</surname> <given-names>Y</given-names></name><name><surname>Belkaid</surname> <given-names>Y</given-names></name><name><surname>O'Shea</surname> <given-names>JJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Distinct requirements for T-bet in gut innate lymphoid cells</article-title><source>The Journal of Experimental Medicine</source><volume>209</volume><fpage>2331</fpage><lpage>2338</lpage><pub-id pub-id-type="doi">10.1084/jem.20122097</pub-id><pub-id pub-id-type="pmid">23209316</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shih</surname> <given-names>HY</given-names></name><name><surname>Sciumè</surname> <given-names>G</given-names></name><name><surname>Mikami</surname> <given-names>Y</given-names></name><name><surname>Guo</surname> <given-names>L</given-names></name><name><surname>Sun</surname> <given-names>HW</given-names></name><name><surname>Brooks</surname> <given-names>SR</given-names></name><name><surname>Urban</surname> <given-names>JF</given-names></name><name><surname>Davis</surname> <given-names>FP</given-names></name><name><surname>Kanno</surname> <given-names>Y</given-names></name><name><surname>O'Shea</surname> <given-names>JJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Developmental acquisition of regulomes underlies innate lymphoid cell functionality</article-title><source>Cell</source><volume>165</volume><fpage>1120</fpage><lpage>1133</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.04.029</pub-id><pub-id pub-id-type="pmid">27156451</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname> <given-names>C</given-names></name><name><surname>Lee</surname> <given-names>JS</given-names></name><name><surname>Gilfillan</surname> <given-names>S</given-names></name><name><surname>Robinette</surname> <given-names>ML</given-names></name><name><surname>Newberry</surname> <given-names>RD</given-names></name><name><surname>Stappenbeck</surname> <given-names>TS</given-names></name><name><surname>Mack</surname> <given-names>M</given-names></name><name><surname>Cella</surname> <given-names>M</given-names></name><name><surname>Colonna</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Unique and redundant functions of NKp46+ ILC3s in models of intestinal inflammation</article-title><source>The Journal of Experimental Medicine</source><volume>212</volume><fpage>1869</fpage><lpage>1882</lpage><pub-id pub-id-type="doi">10.1084/jem.20151403</pub-id><pub-id pub-id-type="pmid">26458769</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sonnenberg</surname> <given-names>GF</given-names></name><name><surname>Monticelli</surname> <given-names>LA</given-names></name><name><surname>Alenghat</surname> <given-names>T</given-names></name><name><surname>Fung</surname> <given-names>TC</given-names></name><name><surname>Hutnick</surname> <given-names>NA</given-names></name><name><surname>Kunisawa</surname> <given-names>J</given-names></name><name><surname>Shibata</surname> <given-names>N</given-names></name><name><surname>Grunberg</surname> <given-names>S</given-names></name><name><surname>Sinha</surname> <given-names>R</given-names></name><name><surname>Zahm</surname> <given-names>AM</given-names></name><name><surname>Tardif</surname> <given-names>MR</given-names></name><name><surname>Sathaliyawala</surname> <given-names>T</given-names></name><name><surname>Kubota</surname> <given-names>M</given-names></name><name><surname>Farber</surname> <given-names>DL</given-names></name><name><surname>Collman</surname> <given-names>RG</given-names></name><name><surname>Shaked</surname> <given-names>A</given-names></name><name><surname>Fouser</surname> <given-names>LA</given-names></name><name><surname>Weiner</surname> <given-names>DB</given-names></name><name><surname>Tessier</surname> <given-names>PA</given-names></name><name><surname>Friedman</surname> <given-names>JR</given-names></name><name><surname>Kiyono</surname> <given-names>H</given-names></name><name><surname>Bushman</surname> <given-names>FD</given-names></name><name><surname>Chang</surname> <given-names>KM</given-names></name><name><surname>Artis</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal Bacteria</article-title><source>Science</source><volume>336</volume><fpage>1321</fpage><lpage>1325</lpage><pub-id pub-id-type="doi">10.1126/science.1222551</pub-id><pub-id pub-id-type="pmid">22674331</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srinivas</surname> <given-names>S</given-names></name><name><surname>Watanabe</surname> <given-names>T</given-names></name><name><surname>Lin</surname> <given-names>CS</given-names></name><name><surname>William</surname> <given-names>CM</given-names></name><name><surname>Tanabe</surname> <given-names>Y</given-names></name><name><surname>Jessell</surname> <given-names>TM</given-names></name><name><surname>Costantini</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus</article-title><source>BMC Developmental Biology</source><volume>1</volume><elocation-id>4</elocation-id><pub-id pub-id-type="doi">10.1186/1471-213x-1-4</pub-id><pub-id pub-id-type="pmid">11299042</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname> <given-names>Z</given-names></name><name><surname>Unutmaz</surname> <given-names>D</given-names></name><name><surname>Zou</surname> <given-names>YR</given-names></name><name><surname>Sunshine</surname> <given-names>MJ</given-names></name><name><surname>Pierani</surname> <given-names>A</given-names></name><name><surname>Brenner-Morton</surname> <given-names>S</given-names></name><name><surname>Mebius</surname> <given-names>RE</given-names></name><name><surname>Littman</surname> <given-names>DR</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Requirement for RORgamma in thymocyte survival and lymphoid organ development</article-title><source>Science</source><volume>288</volume><fpage>2369</fpage><lpage>2373</lpage><pub-id pub-id-type="doi">10.1126/science.288.5475.2369</pub-id><pub-id pub-id-type="pmid">10875923</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szabo</surname> <given-names>SJ</given-names></name><name><surname>Sullivan</surname> <given-names>BM</given-names></name><name><surname>Stemmann</surname> <given-names>C</given-names></name><name><surname>Satoskar</surname> <given-names>AR</given-names></name><name><surname>Sleckman</surname> <given-names>BP</given-names></name><name><surname>Glimcher</surname> <given-names>LH</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells</article-title><source>Science</source><volume>295</volume><fpage>338</fpage><lpage>342</lpage><pub-id pub-id-type="doi">10.1126/science.1065543</pub-id><pub-id pub-id-type="pmid">11786644</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanaka</surname> <given-names>S</given-names></name><name><surname>Suto</surname> <given-names>A</given-names></name><name><surname>Iwamoto</surname> <given-names>T</given-names></name><name><surname>Kashiwakuma</surname> <given-names>D</given-names></name><name><surname>Kagami</surname> <given-names>S</given-names></name><name><surname>Suzuki</surname> <given-names>K</given-names></name><name><surname>Takatori</surname> <given-names>H</given-names></name><name><surname>Tamachi</surname> <given-names>T</given-names></name><name><surname>Hirose</surname> <given-names>K</given-names></name><name><surname>Onodera</surname> <given-names>A</given-names></name><name><surname>Suzuki</surname> <given-names>J</given-names></name><name><surname>Ohara</surname> <given-names>O</given-names></name><name><surname>Yamashita</surname> <given-names>M</given-names></name><name><surname>Nakayama</surname> <given-names>T</given-names></name><name><surname>Nakajima</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Sox5 and c-Maf cooperatively induce Th17 cell differentiation via rorγt induction as downstream targets of Stat3</article-title><source>The Journal of Experimental Medicine</source><volume>211</volume><fpage>1857</fpage><lpage>1874</lpage><pub-id pub-id-type="doi">10.1084/jem.20130791</pub-id><pub-id pub-id-type="pmid">25073789</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Viant</surname> <given-names>C</given-names></name><name><surname>Rankin</surname> <given-names>LC</given-names></name><name><surname>Girard-Madoux</surname> <given-names>MJ</given-names></name><name><surname>Seillet</surname> <given-names>C</given-names></name><name><surname>Shi</surname> <given-names>W</given-names></name><name><surname>Smyth</surname> <given-names>MJ</given-names></name><name><surname>Bartholin</surname> <given-names>L</given-names></name><name><surname>Walzer</surname> <given-names>T</given-names></name><name><surname>Huntington</surname> <given-names>ND</given-names></name><name><surname>Vivier</surname> <given-names>E</given-names></name><name><surname>Belz</surname> <given-names>GT</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Transforming growth factor-β and notch ligands act as opposing environmental cues in regulating the plasticity of type 3 innate lymphoid cells</article-title><source>Science Signaling</source><volume>9</volume><elocation-id>ra46</elocation-id><pub-id pub-id-type="doi">10.1126/scisignal.aaf2176</pub-id><pub-id pub-id-type="pmid">27141930</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vivier</surname> <given-names>E</given-names></name><name><surname>Artis</surname> <given-names>D</given-names></name><name><surname>Colonna</surname> <given-names>M</given-names></name><name><surname>Diefenbach</surname> <given-names>A</given-names></name><name><surname>Di Santo</surname> <given-names>JP</given-names></name><name><surname>Eberl</surname> <given-names>G</given-names></name><name><surname>Koyasu</surname> <given-names>S</given-names></name><name><surname>Locksley</surname> <given-names>RM</given-names></name><name><surname>McKenzie</surname> <given-names>ANJ</given-names></name><name><surname>Mebius</surname> <given-names>RE</given-names></name><name><surname>Powrie</surname> <given-names>F</given-names></name><name><surname>Spits</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Innate lymphoid cells: 10 years on</article-title><source>Cell</source><volume>174</volume><fpage>1054</fpage><lpage>1066</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2018.07.017</pub-id><pub-id pub-id-type="pmid">30142344</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vonarbourg</surname> <given-names>C</given-names></name><name><surname>Mortha</surname> <given-names>A</given-names></name><name><surname>Bui</surname> <given-names>VL</given-names></name><name><surname>Hernandez</surname> <given-names>PP</given-names></name><name><surname>Kiss</surname> <given-names>EA</given-names></name><name><surname>Hoyler</surname> <given-names>T</given-names></name><name><surname>Flach</surname> <given-names>M</given-names></name><name><surname>Bengsch</surname> <given-names>B</given-names></name><name><surname>Thimme</surname> <given-names>R</given-names></name><name><surname>Hölscher</surname> <given-names>C</given-names></name><name><surname>Hönig</surname> <given-names>M</given-names></name><name><surname>Pannicke</surname> <given-names>U</given-names></name><name><surname>Schwarz</surname> <given-names>K</given-names></name><name><surname>Ware</surname> <given-names>CF</given-names></name><name><surname>Finke</surname> <given-names>D</given-names></name><name><surname>Diefenbach</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Regulated expression of nuclear receptor rorγt confers distinct functional fates to NK cell receptor-expressing rorγt(+) innate lymphocytes</article-title><source>Immunity</source><volume>33</volume><fpage>736</fpage><lpage>751</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2010.10.017</pub-id><pub-id pub-id-type="pmid">21093318</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wende</surname> <given-names>H</given-names></name><name><surname>Lechner</surname> <given-names>SG</given-names></name><name><surname>Cheret</surname> <given-names>C</given-names></name><name><surname>Bourane</surname> <given-names>S</given-names></name><name><surname>Kolanczyk</surname> <given-names>ME</given-names></name><name><surname>Pattyn</surname> <given-names>A</given-names></name><name><surname>Reuter</surname> <given-names>K</given-names></name><name><surname>Munier</surname> <given-names>FL</given-names></name><name><surname>Carroll</surname> <given-names>P</given-names></name><name><surname>Lewin</surname> <given-names>GR</given-names></name><name><surname>Birchmeier</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The transcription factor c-Maf controls touch receptor development and function</article-title><source>Science</source><volume>335</volume><fpage>1373</fpage><lpage>1376</lpage><pub-id pub-id-type="doi">10.1126/science.1214314</pub-id><pub-id pub-id-type="pmid">22345400</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wheaton</surname> <given-names>JD</given-names></name><name><surname>Yeh</surname> <given-names>CH</given-names></name><name><surname>Ciofani</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Cutting edge: c-maf is required for regulatory T cells to adopt rorγt<sup>+</sup> and Follicular Phenotypes</article-title><source>The Journal of Immunology</source><volume>199</volume><fpage>3931</fpage><lpage>3936</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1701134</pub-id><pub-id pub-id-type="pmid">29127150</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname> <given-names>M</given-names></name><name><surname>Pokrovskii</surname> <given-names>M</given-names></name><name><surname>Ding</surname> <given-names>Y</given-names></name><name><surname>Yi</surname> <given-names>R</given-names></name><name><surname>Au</surname> <given-names>C</given-names></name><name><surname>Harrison</surname> <given-names>OJ</given-names></name><name><surname>Galan</surname> <given-names>C</given-names></name><name><surname>Belkaid</surname> <given-names>Y</given-names></name><name><surname>Bonneau</surname> <given-names>R</given-names></name><name><surname>Littman</surname> <given-names>DR</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>c-MAF-dependent regulatory T cells mediate immunological tolerance to a gut pathobiont</article-title><source>Nature</source><volume>554</volume><fpage>373</fpage><lpage>377</lpage><pub-id pub-id-type="doi">10.1038/nature25500</pub-id><pub-id pub-id-type="pmid">29414937</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>Y</given-names></name><name><surname>Ochando</surname> <given-names>JC</given-names></name><name><surname>Bromberg</surname> <given-names>JS</given-names></name><name><surname>Ding</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Identification of a distant T-bet enhancer responsive to IL-12/Stat4 and IFNgamma/Stat1 signals</article-title><source>Blood</source><volume>110</volume><fpage>2494</fpage><lpage>2500</lpage><pub-id pub-id-type="doi">10.1182/blood-2006-11-058271</pub-id><pub-id pub-id-type="pmid">17575072</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zenewicz</surname> <given-names>LA</given-names></name><name><surname>Yancopoulos</surname> <given-names>GD</given-names></name><name><surname>Valenzuela</surname> <given-names>DM</given-names></name><name><surname>Murphy</surname> <given-names>AJ</given-names></name><name><surname>Stevens</surname> <given-names>S</given-names></name><name><surname>Flavell</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease</article-title><source>Immunity</source><volume>29</volume><fpage>947</fpage><lpage>957</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2008.11.003</pub-id><pub-id pub-id-type="pmid">19100701</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname> <given-names>Y</given-names></name><name><surname>Valdez</surname> <given-names>PA</given-names></name><name><surname>Danilenko</surname> <given-names>DM</given-names></name><name><surname>Hu</surname> <given-names>Y</given-names></name><name><surname>Sa</surname> <given-names>SM</given-names></name><name><surname>Gong</surname> <given-names>Q</given-names></name><name><surname>Abbas</surname> <given-names>AR</given-names></name><name><surname>Modrusan</surname> <given-names>Z</given-names></name><name><surname>Ghilardi</surname> <given-names>N</given-names></name><name><surname>de Sauvage</surname> <given-names>FJ</given-names></name><name><surname>Ouyang</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens</article-title><source>Nature Medicine</source><volume>14</volume><fpage>282</fpage><lpage>289</lpage><pub-id pub-id-type="doi">10.1038/nm1720</pub-id><pub-id pub-id-type="pmid">18264109</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zuberbuehler</surname> <given-names>MK</given-names></name><name><surname>Parker</surname> <given-names>ME</given-names></name><name><surname>Wheaton</surname> <given-names>JD</given-names></name><name><surname>Espinosa</surname> <given-names>JR</given-names></name><name><surname>Salzler</surname> <given-names>HR</given-names></name><name><surname>Park</surname> <given-names>E</given-names></name><name><surname>Ciofani</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The transcription factor c-Maf is essential for the commitment of IL-17-producing γδ T cells</article-title><source>Nature Immunology</source><volume>20</volume><fpage>73</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1038/s41590-018-0274-0</pub-id><pub-id pub-id-type="pmid">30538336</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.52549.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Rath</surname><given-names>Satyajit</given-names></name><role>Reviewing Editor</role><aff><institution>Indian Institute of Science Education and Research (IISER)</institution><country>India</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Withers</surname><given-names>David</given-names> </name><role>Reviewer</role></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>This paper describes that cMAF regulates the balance between ILC1 and ILC3, by controlling T-bet expression. This occurs in the CCR6<sup>-</sup> ILC3 population. cMAF expression regulates the dynamic acquisition of type 1 effector functions as deletion of this factor results in upregulation of NKp46, which was previously been found to be regulated by T-bet. While it is not novel that cMAF is involved in regulating the balance of ILC3 and ILC1, the present paper examines mechanisms involved. The authors provide convincing data that c-Maf negatively regulates the transition of ILC3 to ILC1 like cells. How ILC plasticity is regulated is an important in topical area of research and the identification of the role of c-Maf significantly adds to our understanding. The data provided are convincing, and support, with more insight in certain areas, a very recent paper (Parker et al., 2019), a publication that was released after completion of the present manuscript.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;c-Maf restrains T-bet-driven programming of CCR6-negative group 3 innate lymphoid cells&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by two peer reviewers, and the evaluation has been overseen by Satyajit Rath as the Senior and Reviewing Editor. The following individual involved in review of your submission has agreed to reveal their identity: David Withers (Reviewer #2).</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>Essential revisions:</p><p>1) The claim that c-Maf is required for maintenance of the total CCR6<sup>-</sup> ILC3 is not really supported by the data. There is a reduction but this reduction is less than 30-40%. The strongest reduction is seen in NKp46<sup>-</sup>CCR6<sup>-</sup> cells (Figure 2). A more likely conclusion would be that cMAF is required for maintenance of the NKp46-CCR6-ILC3s. This should be clarified.</p><p>2) Whereas the authors show that IL-1b and IL-18 can upregulate cMAF, the effects of IL-12 do not get much attention. IL-12 is a powerful inducer of ILC3 to ILC1 conversion and IL-12 receptor deficient mice show a strong increase in NKp46<sup>+</sup>RORgt<sup>+</sup> ILC3 (Vonarbourg et al., 2010). One would expect a strong effect of IL-12 on c-Maf expression. Indeed, inspection of Figure 3E reveals a significant reduction of cMAF by IL-12. This should be addressed.</p><p>3) In Figure 1, the authors should show total numbers of ILC populations rather than only percentages. Total numbers would clarify whether other populations were really unaffected.</p><p>4) Again, in Figure 1, it would be useful to compare CCR6<sup>-</sup>NKp46<sup>-</sup> and CCR6<sup>-</sup>NKp46<sup>+</sup> cell populations for further clarity. It is not necessary to group both CCR6<sup>-</sup> populations together. Since the CCR6<sup>-</sup>NKp46<sup>-</sup> cells are considered to be the precursors, expression of c-Maf here is of interest.</p><p>5) Any evidence for T-bet binding in the <italic>Maf</italic> locus to regulate its expression, building on the observation in Figure 3D, would be very useful to add.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.52549.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) The claim that c-Maf is required for maintenance of the total CCR6<sup>-</sup> ILC3 is not really supported by the data. There is a reduction but this reduction is less than 30-40%. The strongest reduction is seen in NKp46<sup>-</sup>CCR6<sup>-</sup> cells (Figure 2). A more likely conclusion would be that cMAF is required for maintenance of the NKp46<sup>-</sup>CCR6<sup>-</sup>ILC3s. This should be clarified.</p></disp-quote><p>We agree with the reviewer that our analysis of c<sup>-</sup>Maf-deficient ILC3s in Figure 1 was unprecise because we divided ILC3s solely into the CCR6<sup>-</sup> and CCR6<sup>+</sup> ILC3 subsets, neglecting potential differences between NKp46<sup>+</sup> vs. NKp46<sup>-</sup> CCR6<sup>-</sup> ILC3s. Therefore, we revisited our data and now present a comprehensive characterization of c-Maf-deficient ILC3s in Figure 1, by directly comparing NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s, NKp46<sup>-</sup> CCR6<sup>-</sup> ILC3s and NKp46<sup>-</sup> CCR6<sup>+</sup> ILC3s (new Figure 1B, D-G).</p><p>This analysis indeed revealed that the NKp46<sup>-</sup> CCR6<sup>-</sup> ILC3 subset was selectively reduced in <italic>Rorc</italic><sup>Cre</sup><italic>Maf</italic><sup>fl/fl</sup> mice, whereas total numbers of NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s and NKp46<sup>-</sup> CCR6<sup>+</sup> ILC3s were normal or even slightly increased as compared to controls (new Figure 1D, subsection “c-Maf specifically preserves the type 3 identity of CCR6<sup>-</sup> ILC3s”, second paragraph). Thus, we corrected our claim, now concluding that c-Maf is specifically required for the maintenance of intestinal NKp46<sup>-</sup> CCR6<sup>-</sup> ILC3 (see the third paragraph of the aforementioned subsection). Given the fact that NKp46<sup>-</sup> CCR6<sup>-</sup> ILC3 are considered to contain precursors of NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s, the selective loss of NKp46<sup>-</sup> CCR6<sup>-</sup> ILC3s in <italic>Rorc</italic><sup>Cre</sup><italic>Maf</italic><sup>fl/fl</sup> mice suggested an enhanced differentiation from NKp46<sup>-</sup> to NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s in the absence of c-Maf, which is in line with our concept that c-Maf-deficiency results in an amplified type 1 conversion of CCR6<sup>-</sup> ILC3s (subsection “c-Maf suppresses the acquisition of type 1 properties by CCR6<sup>-</sup> ILC3s”, second paragraph).</p><disp-quote content-type="editor-comment"><p>2) Whereas the authors show that IL-1b and IL-18 can upregulate cMAF, the effects of IL-12 do not get much attention. IL-12 is a powerful inducer of ILC3 to ILC1 conversion and IL-12 receptor deficient mice show a strong increase in NKp46<sup>+</sup>RORgt<sup>+</sup> ILC3 (Vonarbourg et al., 2010). One would expect a strong effect of IL-12 on c-Maf expression. Indeed, inspection of Figure 3E reveals a significant reduction of cMAF by IL-12. This should be addressed.</p></disp-quote><p>We followed the reviewers suggestion and further explored the role of IL-12 in c-Maf regulation. First, we comparatively assessed c-Maf expression in siLP NKp46<sup>+</sup> ILC3s from <italic>Il12a</italic><sup>-/-</sup> and wild-type control mice. However, we could not detect any alteration in c-Maf expression in the absence of IL-12 (new Figure 3—figure supplement 2C, subsection “IL-1β- and IL-18-mediated NF-κb and Notch signalling promote c-Maf expression in CCR6<sup>-</sup> ILC3s”, second paragraph), suggesting that c-Maf expression is largely independent of IL-12 at least during homeostatic conditions.</p><p>Second, we tested whether IL-12 was capable to interfere with the IL-1ß/IL-18-mediated induction of c-Maf expression. Yet, in vitro stimulation of NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s with IL-1ß/IL-18 plus IL-12, as compared to IL-1ß/IL-18 stimulation alone, did not result in a reduction of c-Maf expression (new Figure 3—figure supplement 2B, see the aforementioned paragraph), questioning a dominant role of IL-12 in regulation of c-Maf expression.</p><p>We have included the above mentioned data as supplementary figures (new Figure 3—figure supplement 2B, C) in the revised version of our manuscript.</p><disp-quote content-type="editor-comment"><p>3) In Figure 1, the authors should show total numbers of ILC populations rather than only percentages. Total numbers would clarify whether other populations were really unaffected.</p></disp-quote><p>As suggested by the reviewer we now show in Figure 1 total numbers of the different siLP ILC populations (ILC1s, ILC2s, ILC3s) (new Figure 1C, subsection “c-Maf specifically preserves the type 3 identity of CCR6<sup>-</sup> ILC3s”, second paragraph) as well as of the different siLP ILC3 subsets (NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s, NKp46<sup>-</sup> CCR6<sup>-</sup> ILC3s and NKp46<sup>-</sup> CCR6<sup>+</sup> ILC3s) (new Figure 1D, see the aforementioned paragraph).</p><p>This analysis demonstrated that frequencies and total numbers of ILC1s and ILC2s were significantly increased in <italic>Rorc</italic><sup>Cre</sup><italic>Maf</italic><sup>fl/fl</sup> mice as compared to controls (new Figure 1C, subsection “c-Maf specifically preserves the type 3 identity of CCR6<sup>-</sup> ILC3s, second paragraph). For ILC3s, we detected reduced relative proportions among Lin<sup>-</sup> CD127<sup>+</sup> cells, while total numbers were not changed in <italic>Rorc</italic><sup>Cre</sup><italic>Maf</italic><sup>fl/fl</sup> mice (new Figure 1C, see the aforementioned paragraph). However, among ILC3s, we found a selective loss of NKp46<sup>-</sup> CCR6<sup>-</sup> ILC3s (new Figure 1D, see the aforementioned paragraph). In contrast, total numbers of NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s and NKp46<sup>-</sup> CCR6<sup>+</sup> ILC3s were not significantly changed (new Figure 1D, see the aforementioned paragraph).</p><disp-quote content-type="editor-comment"><p>4) Again, in Figure 1, it would be useful to compare CCR6<sup>-</sup>NKp46<sup>-</sup> and CCR6<sup>-</sup>NKp46<sup>+</sup> cell populations for further clarity. It is not necessary to group both CCR6<sup>-</sup> populations together. Since the CCR6<sup>-</sup>NKp46<sup>-</sup> cells are considered to be the precursors, expression of c-Maf here is of interest.</p></disp-quote><p>As mentioned already in response to point 1, we now directly compare NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s, NKp46<sup>-</sup> CCR6<sup>-</sup> ILC3s and NKp46<sup>-</sup> CCR6<sup>+</sup> ILC3s in Figure 1 (new Figure 1B, D-G) to better dissect the phenotype of CCR6<sup>-</sup> ILC3s based on NKp46 expression.</p><p>The analysis of c-Maf expression (new Figure 1B, subsection “c-Maf specifically preserves the type 3 identity of CCR6<sup>-</sup> ILC3s”, first paragraph) showed that c-Maf was particularly highly expressed by NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s at levels comparable to RORγt<sup>+</sup> CD4<sup>+</sup> T cells. This is in line with our findings, that c-Maf expression (like NKp46 expression itself) in CCR6<sup>-</sup> ILC3s is dependent on T-bet and thus tightly correlates with T-bet expression (new Figure 2A, subsection “c-Maf suppresses the acquisition of type 1 properties by CCR6<sup>-</sup> ILC3s”, second paragraph). In contrast, c-Maf expression level of NKp46<sup>-</sup> CCR6<sup>-</sup> ILC3s were more heterogenous (new Figure 1B). However, also in NKp46<sup>-</sup> CCR6<sup>-</sup> ILC3s we observed tight correlation of c-Maf and T-bet expression (new Figure 2A, see the aforementioned paragraph). Together with the selective loss of NKp46<sup>-</sup> CCR6<sup>-</sup> ILC3s in <italic>Rorc</italic><sup>Cre</sup><italic>Maf</italic><sup>fl/fl</sup> mice, these data suggest an enhanced T-bet-dependent differentiation from the NKp46<sup>-</sup> CCR6<sup>-</sup> to the NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3 compartment in the absence of c-Maf (see the aforementioned paragraph).</p><p>In addition to the analysis of c-Maf expression, we also revisited our data to directly compare RORγt (new Figure 1E) and IL-17A/IL-22 expression (new Figure 1F and 1G) between NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s, NKp46<sup>-</sup> CCR6<sup>-</sup> ILC3s and NKp46<sup>-</sup> CCR6<sup>+</sup> ILC3s in <italic>Rorc</italic><sup>Cre</sup><italic>Maf</italic><sup>fl/fl</sup> mice and control mice. This analysis showed that RORγt protein levels (subsection “c-Maf specifically preserves the type 3 identity of CCR6<sup>-</sup> ILC3s”, third paragraph) as well as frequencies of IL-17A and IL-22 producers (see the fourth paragraph of the aforementioned subsection) were significantly reduced in both NKp46<sup>+</sup> and NKp46<sup>-</sup> CCR6<sup>-</sup> ILC3s in the absence of c-Maf, whereas NKp46<sup>-</sup> CCR6<sup>+</sup> ILC3s were unaffected.</p><disp-quote content-type="editor-comment"><p>5) Any evidence for T-bet binding in the Maf locus to regulate its expression, building on the observation in Figure 3D, would be very useful to add.</p></disp-quote><p>We thank the reviewer for bringing up this very interesting point. In order to gain evidence for a direct binding of T-bet to <italic>Maf</italic>, we performed a detailed in silicoanalysis of the <italic>Maf</italic> locus using published ATAC-Seq data from NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s [1] and T-bet ChIP-seq data from Th1 cells [2]. We also performed motif analysis using HOMER to identify potential T-bet binding sites across the <italic>Maf</italic> locus. We present the results of these analyses in the new Figure 3—figure supplement 1 and in the text (subsection “c-Maf expression in CCR6<sup>-</sup> ILC3s is dependent on T-bet”, second paragraph).</p><p>As a result, based on the ATAC-Seq data, we find that the <italic>Maf</italic> locus in NKp46<sup>+</sup> ILC3s is only accessible in a very specific and narrow region (stretching ca. 1kb) upstream of the TSS (new Figure 3—figure supplement 1A). Interestingly, this open chromatin region overlaps with two highly conserved non-coding sequences (CNS-0.5 and CNS<sup>-1</sup>) upstream of <italic>Maf</italic>, suggesting an important role of these regions in regulation of <italic>Maf</italic> in NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s (new Figure 3—figure supplement 1A).</p><p>Importantly, analysis of T-bet ChIP-seq data from Th1 cells revealed a striking overlap of T-bet binding peaks with CNS-0.5 and CNS<sup>-1</sup> (new Figure 3—figure supplement 1B). Furthermore, T-bet motif analysis identified several T-bet binding sites within CNS-0.5 and CNS<sup>-1</sup> (new Figure 3—figure supplement 1C and D).</p><p>Taken together, these data strongly suggest that T-bet directly binds to <italic>Maf</italic> in NKp46<sup>+</sup> CCR6<sup>-</sup> ILC3s thereby promoting c-Maf expression.</p></body></sub-article></article>